<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" id="jep70029" xml:lang="en" article-type="review-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">J Eval Clin Pract</journal-id><journal-id journal-id-type="iso-abbrev">J Eval Clin Pract</journal-id><journal-id journal-id-type="pmc-domain-id">379</journal-id><journal-id journal-id-type="pmc-domain">blackwellopen</journal-id><journal-id journal-id-type="publisher-id">JEP</journal-id><journal-title-group><journal-title>Journal of Evaluation in Clinical Practice</journal-title></journal-title-group><issn pub-type="ppub">1356-1294</issn><issn pub-type="epub">1365-2753</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>Wiley Open Access Collection</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC11865632</article-id><article-id pub-id-type="pmcid-ver">PMC11865632.1</article-id><article-id pub-id-type="pmcaid">11865632</article-id><article-id pub-id-type="pmcaiid">11865632</article-id><article-id pub-id-type="pmid">40012165</article-id><article-id pub-id-type="doi">10.1111/jep.70029</article-id><article-id pub-id-type="publisher-id">JEP70029</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="overline"><subject>Review Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Review Article</subject></subj-group></article-categories><title-group><article-title>Systematic Review of Outcome Measures in Pharmacologically Managed Chronic Pain: Informing a New Outcome Framework for Healthcare Provider&#8208;Led Pharmacotherapy Services</article-title></title-group><contrib-group><contrib id="jep70029-cr-0001" contrib-type="author"><name name-style="western"><surname>Sharaf</surname><given-names initials="A">Abdulrahman</given-names></name><xref rid="jep70029-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="jep70029-aff-0002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib id="jep70029-cr-0002" contrib-type="author" corresp="yes"><name name-style="western"><surname>Dunlop</surname><given-names initials="E">Emma</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-0719-7614</contrib-id><xref rid="jep70029-aff-0001" ref-type="aff">
<sup>1</sup>
</xref><address><email>emma.dunlop@strath.ac.uk</email></address></contrib><contrib id="jep70029-cr-0003" contrib-type="author"><name name-style="western"><surname>Weir</surname><given-names initials="N">Natalie</given-names></name><xref rid="jep70029-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="jep70029-cr-0004" contrib-type="author"><name name-style="western"><surname>Newham</surname><given-names initials="R">Rosemary</given-names></name><xref rid="jep70029-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib><contrib id="jep70029-cr-0005" contrib-type="author"><name name-style="western"><surname>Alsalah</surname><given-names initials="S">Sumaya</given-names></name><xref rid="jep70029-aff-0003" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib id="jep70029-cr-0006" contrib-type="author"><name name-style="western"><surname>Bennie</surname><given-names initials="M">Marion</given-names></name><xref rid="jep70029-aff-0001" ref-type="aff">
<sup>1</sup>
</xref></contrib></contrib-group><aff id="jep70029-aff-0001">
<label>
<sup>1</sup>
</label>
<named-content content-type="organisation-division">Strathclyde Institute of Pharmacy and Biomedical Sciences</named-content>
<institution>University of Strathclyde</institution>
<city>Glasgow</city>
<country country="GB">UK</country>
</aff><aff id="jep70029-aff-0002">
<label>
<sup>2</sup>
</label>
<named-content content-type="organisation-division">Department of Clinical Pharmacy</named-content>
<institution>Salmaniya Medical Complex, Government Hospitals</institution>
<city>Manama</city>
<country country="BH">Bahrain</country>
</aff><aff id="jep70029-aff-0003">
<label>
<sup>3</sup>
</label>
<named-content content-type="organisation-division">Department of Pharmacy</named-content>
<institution>Primary Healthcare Centers</institution>
<city>Manama</city>
<country country="BH">Bahrain</country>
</aff><author-notes><corresp id="correspondenceTo"><label>*</label><bold>Correspondence:</bold> Emma Dunlop (<email>emma.dunlop@strath.ac.uk</email>)<break/></corresp></author-notes><pub-date pub-type="epub"><day>26</day><month>2</month><year>2025</year></pub-date><pub-date pub-type="ppub"><month>3</month><year>2025</year></pub-date><volume>31</volume><issue seq="20">2</issue><issue-id pub-id-type="pmc-issue-id">483038</issue-id><issue-id pub-id-type="doi">10.1111/jep.v31.2</issue-id><elocation-id>e70029</elocation-id><history><date date-type="rev-recd"><day>20</day><month>12</month><year>2024</year></date><date date-type="received"><day>18</day><month>7</month><year>2024</year></date><date date-type="accepted"><day>02</day><month>2</month><year>2025</year></date></history><pub-history><event event-type="pmc-release"><date><day>27</day><month>02</month><year>2025</year></date></event><event event-type="pmc-live"><date><day>28</day><month>02</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-03-04 11:25:34.823"><day>04</day><month>03</month><year>2025</year></date></event></pub-history><permissions><copyright-statement content-type="article-copyright">&#169; 2025 The Author(s). <italic toggle="yes">Journal of Evaluation in Clinical Practice</italic> published by John Wiley &amp; Sons Ltd.</copyright-statement><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open access article under the terms of the <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="JEP-31-0.pdf"/><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pdf" xlink:href="file:JEP-31-0.pdf"/><abstract><title>ABSTRACT</title><sec id="jep70029-sec-0010"><title>Background and Objective</title><p>Chronic pain represents a global burden, highlighting the necessity for accurate outcome measures in treatment evaluation. This systematic review aims to identify what outcome measures and tools are applied in chronic pain primary care&#8208;based pharmacotherapy services.</p></sec><sec id="jep70029-sec-0020"><title>Databases and Data Treatment</title><p>The MEDLINE, Embase, and CINAHL databases, along with the reference lists of published articles, were systematically searched from 2013 to July 2023. This search included observational studies that employed pharmacological interventions recommended by the World Health Organisation pain ladder and the Scottish Intercollegiate Guidelines Network guidelines. The studies targeted chronic pain patients treated in outpatient settings and examined five predefined outcomes: health&#8208;related quality of life (HRQoL), cost&#8208;effectiveness, medication optimisation, adverse events, and patient experience. The quality of included studies was assessed using the Newcastle&#8208;Ottawa Scale (NOS).</p></sec><sec id="jep70029-sec-0030"><title>Results</title><p>Among the 23 studies included a total of 51 outcome measurement tools were employed to assess the five predefined outcomes, involving 44,472 patients with chronic pain. Fifteen were cohort studies, while 8 were cross&#8208;sectional surveys or questionnaire&#8208;based. Most studies focused on one to two outcomes only (<italic toggle="yes">n</italic>&#8201;=&#8201;19; 82.6%). HRQoL emerged as the primary outcome studied across all 23 studies (100%), predominantly assessed through the Brief Pain Inventory (BPI) tool (<italic toggle="yes">n</italic>&#8201;=&#8201;9; 39.1%). Conversely, the least studied outcomes were medication optimisation and cost&#8208;effectiveness. The timing of measurement post&#8208;intervention and follow&#8208;up durations displayed significant variability across the studies.</p></sec><sec id="jep70029-sec-0040"><title>Conclusions</title><p>This review identifies gaps in enabling a more holistic assessment of pharmacotherapy services and underscores the need for enhanced consistency via standardised tools in clinical practice.</p></sec></abstract><kwd-group><kwd id="jep70029-kwd-0001">chronic pain</kwd><kwd id="jep70029-kwd-0002">medicines</kwd><kwd id="jep70029-kwd-0003">outcome measurement</kwd><kwd id="jep70029-kwd-0004">outcomes</kwd><kwd id="jep70029-kwd-0005">pharmacological</kwd><kwd id="jep70029-kwd-0006">pharmacy</kwd><kwd id="jep70029-kwd-0007">systematic review</kwd></kwd-group><funding-group><award-group id="funding-0001"><funding-source>The authors received no specific funding for this work.</funding-source></award-group></funding-group><counts><fig-count count="2"/><table-count count="8"/><page-count count="17"/><word-count count="9210"/></counts><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>source-schema-version-number</meta-name><meta-value>2.0</meta-value></custom-meta><custom-meta><meta-name>cover-date</meta-name><meta-value>March 2025</meta-value></custom-meta><custom-meta><meta-name>details-of-publishers-convertor</meta-name><meta-value>Converter:WILEY_ML3GV2_TO_JATSPMC version:6.5.4 mode:remove_FC converted:27.02.2025</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="jep70029-sec-0050"><label>1</label><title>Introduction</title><p>Chronic pain is defined as nonmalignant pain lasting more than 3 months, including: primary chronic pain not attributed to other conditions; or secondary chronic pain resulting from an underlying disease or condition [<xref rid="jep70029-bib-0001" ref-type="bibr">1</xref>, <xref rid="jep70029-bib-0002" ref-type="bibr">2</xref>]. Chronic pain is a complex debilitating condition affecting millions of individuals worldwide [<xref rid="jep70029-bib-0003" ref-type="bibr">3</xref>]. The treatment of chronic pain frequently involves the use of various medicines, either as monotherapy or in combination, including paracetamol, opioids, nonsteroidal anti&#8208;inflammatory drugs (NSAIDs), antidepressants, and anticonvulsants [<xref rid="jep70029-bib-0004" ref-type="bibr">4</xref>]. It was reported that the medication&#8208;based dimension of chronic pain treatment was used in 85% of patients with chronic pain, while 25% reported incorporating nonpharmacological treatments into their treatment approach [<xref rid="jep70029-bib-0005" ref-type="bibr">5</xref>]. This underscores the need for assessment tools focused on medication use within routine care. Such tools should offer comprehensive evaluation across various domains while remaining practical and feasible beyond the confines of clinical trials. Moreover, whilst clinical trials provide valuable insights into the efficacy of pain&#8208;management interventions, understanding how the measures perform in real&#8208;world settings is essential for ensuring their relevance, reliability and validity in everyday practice.</p><p>There is significant variation in the use of outcome measures in chronic pain management by healthcare providers and researchers [<xref rid="jep70029-bib-0006" ref-type="bibr">6</xref>]. Additionally, existing evidence identifying these measures may lack inclusivity, due to being limited to specific types of chronic pain and targeting particular methods (e.g., patient self&#8208;report), and not encompassing all possible outcomes [<xref rid="jep70029-bib-0006" ref-type="bibr">6</xref>, <xref rid="jep70029-bib-0007" ref-type="bibr">7</xref>, <xref rid="jep70029-bib-0008" ref-type="bibr">8</xref>]. In a published article on development of an outcome framework for pharmacotherapy and disease management services in Scotland, consensus involving pharmacy professionals was reached on five key outcome areas for the framework: patient experience; medication&#8208;related adverse events; cost&#8208;effectiveness; medication optimisation; and health&#8208;related quality of life (HRQoL) [<xref rid="jep70029-bib-0009" ref-type="bibr">9</xref>]. In Scotland, the importance of identifying useful pain outcomes measures is exemplified by the expanding role of pharmacists, who have recently integrated within general practice. The Scottish Government funded the recruitment of full time General Practice Clinical Pharmacists as part of plans to alleviate pressures in primary care. Their role in general practice includes the delivery of a &#8216;Pharmacotherapy Service&#8217;, where they may offer pharmacy&#8208;led pain clinics [<xref rid="jep70029-bib-0010" ref-type="bibr">10</xref>]. The identification of appropriate outcome measures for use in such pharmacist&#8208;led clinics within general practice will help evaluate the effectiveness of the Pharmacotherapy Service in Scotland [<xref rid="jep70029-bib-0010" ref-type="bibr">10</xref>] and will support evidence&#8208;based service delivery within Scotland's primary care sector.</p><p>To identify suitable outcomes measures for potential use in pharmacy&#8208;led pharmacotherapy services, such as the Scottish Pharmacotherapy Service, the aim of this systematic review was to identify and evaluate outcome measures and associated tools applied in primary care&#8208;based pharmacotherapy pain management services provided by healthcare professionals.</p></sec><sec sec-type="methods" id="jep70029-sec-0060"><label>2</label><title>Methods</title><p>A systematic review can be defined as attempting to collate empirical evidence from a relatively smaller number of studies pertaining to a focused research question [<xref rid="jep70029-bib-0011" ref-type="bibr">11</xref>]. Therefore, given the scope of this study, a systematic review methodology was conducted and reported following the Preferred Reporting Items for Systematic Reviews and Meta&#8208;Analyses (PRISMA) guidelines [<xref rid="jep70029-bib-0012" ref-type="bibr">12</xref>]. The review was registered in PROSPERO with the following ID (CRD42023442201).</p><sec id="jep70029-sec-0070"><label>2.1</label><title>Search Strategy and Data Sources</title><p>A search was conducted after consultation with a reference librarian, and searches were performed in the CINAHL, EMBASE, and MEDLINE databases from 2013 to the present (July 2023). The search strategy combined MeSH terms and keywords related to: chronic pain; analgesics; opioids; outpatient; and primary care. Additionally, a manual search of the reference lists of retrieved journal articles, including systematic reviews, was performed to identify any additional relevant records that met the inclusion criteria. The complete search strategy can be found in the Supporting Information Tables&#160;<xref rid="jep70029-suppl-0001" ref-type="supplementary-material">S1</xref> and&#160;<xref rid="jep70029-suppl-0002" ref-type="supplementary-material">S2</xref>.</p></sec><sec id="jep70029-sec-0080"><label>2.2</label><title>Inclusion Criteria</title><p>The included studies in this systematic review met the following criteria: observational studies were selected to reflect real&#8208;world clinical practice and included participants aged 18 years and above with non&#8208;cancer&#8208;related chronic pain, who were receiving treatment and follow&#8208;up in outpatient settings. Chronic pain was defined as per the International Association for the Study of Pain (IASP) [<xref rid="jep70029-bib-0001" ref-type="bibr">1</xref>] and the National Institute for Health and Care Excellence (NICE) guidelines NG193 [<xref rid="jep70029-bib-0002" ref-type="bibr">2</xref>]. Studies should be using measures to assess the 5 predefined outcomes in chronic pain management services. The interventions encompassed treatments recommended by the World Health Organisation (WHO) pain ladder [<xref rid="jep70029-bib-0013" ref-type="bibr">13</xref>] and the Scottish Intercollegiate Guidelines Network (SIGN) guidelines [<xref rid="jep70029-bib-0014" ref-type="bibr">14</xref>], including: paracetamol; NSAIDs; opioids; antidepressants; anticonvulsants; and topical treatments such as capsaicin, rubefacients, and lidocaine. Pharmacological treatments were included given the study's focus on predefined criteria related to pharmacotherapy and the Scottish pharmacotherapy service and outcomes framework. Exclusions from this review included non&#8208;English language studies, clinical trials, case reports, case series, and narrative reviews. All studies examining cancer&#8208;related chronic pain or acute pain were also excluded. Interventions solely involving non&#8208;pharmacologic treatments (e.g., cognitive&#8208;behavioural therapy, etc.) were excluded as well.</p></sec><sec id="jep70029-sec-0090"><label>2.3</label><title>Study Selection</title><p>The study selection process was conducted using the Rayyan&#169; software [<xref rid="jep70029-bib-0015" ref-type="bibr">15</xref>]. After eliminating any duplicated records, two reviewers (A.S. and S.A.) independently performed title and abstract screening, and screening of full texts of potentially eligible studies. Excluded studies during full&#8208;text screening were documented, with a justification provided for their exclusion. In cases where discrepancies arose, a third reviewer (N.W. or E.D.) were involved to resolve disagreements.</p></sec><sec id="jep70029-sec-0100"><label>2.4</label><title>Data Extraction</title><p>Reviewer A.S. independently extracted the relevant data from the included studies and was validated by the second reviewer, S.A, using a pilot&#8208;tested data extraction Microsoft Excel&#169; sheet (see Supporting Information Tables&#160;<xref rid="jep70029-suppl-0003" ref-type="supplementary-material">[Link]</xref>, <xref rid="jep70029-suppl-0004" ref-type="supplementary-material">[Link]</xref>, <xref rid="jep70029-suppl-0005" ref-type="supplementary-material">[Link]</xref>). Table&#160;<xref rid="jep70029-suppl-0003" ref-type="supplementary-material">S3</xref> outlines the broader context of the studies, including their aims and key findings; Table&#160;<xref rid="jep70029-suppl-0004" ref-type="supplementary-material">S4</xref> focuses on the populations studied, types of pain assessed, and therapies included; and Table&#160;<xref rid="jep70029-suppl-0005" ref-type="supplementary-material">S5</xref> highlights the outcome measurement tools, which are central to our study's purpose. Throughout the data extraction process, any discrepancies or uncertainties that emerged were resolved through discussions and consensus with the authors, N.W. and E.D.</p><p>The data extracted from the included studies encompassed baseline study characteristics, including: authors; publication year; sample size; study aim; characteristics of the study population; description of the intervention and comparison; assessed outcomes; key findings; study groups; setting; type of pain; medication administered; and involvement of healthcare professional. Additionally, details on the outcome measures from the studies were extracted, which included: information on the measurement tools employed; performer of the outcome assessment (i.e. patient or specific healthcare professional); if the tool was validated; and frequency of tool use. All measurement tools were extracted from the included studies and classified according to the five predefined outcomes. Working definitions for each outcome were developed based on a comprehensive search in recently published studies and health organisations [<xref rid="jep70029-bib-0016" ref-type="bibr">16</xref>, <xref rid="jep70029-bib-0017" ref-type="bibr">17</xref>, <xref rid="jep70029-bib-0018" ref-type="bibr">18</xref>, <xref rid="jep70029-bib-0019" ref-type="bibr">19</xref>, <xref rid="jep70029-bib-0020" ref-type="bibr">20</xref>, <xref rid="jep70029-bib-0021" ref-type="bibr">21</xref>, <xref rid="jep70029-bib-0022" ref-type="bibr">22</xref>] to assist in the clarification of the outcomes. The definitions of the predefined outcomes are outlined in Table&#160;<xref rid="jep70029-tbl-0001" ref-type="table">1</xref>. During data extraction, relevant outcome measures were categorised into domains depending on the areas they covered. Where possible, this process utilised existing domains, such as the World Health Organisation HRQoL domains and subdomains [<xref rid="jep70029-bib-0024" ref-type="bibr">24</xref>].</p><table-wrap position="float" id="jep70029-tbl-0001" content-type="Table" orientation="portrait"><label>Table 1</label><caption><p>Definition of the outcomes.</p></caption><table frame="hsides" rules="groups"><col style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" align="left" span="1"/><col style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" align="center" span="1"/><thead><tr style="border-bottom:solid 1px #000000"><th align="left" rowspan="1" colspan="1">Outcomes [<xref rid="jep70029-bib-0009" ref-type="bibr">9</xref>]</th><th align="center" rowspan="1" colspan="1">Working definition</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Health&#8208;related quality of life</td><td align="center" rowspan="1" colspan="1">Value is assigned to the duration of life, as modified by impairments, functional states, perceptions, and social opportunities influenced by disease, injury, treatment, or policy. This concept encompasses physical health (pain, sleep), psychological health (positive and negative feelings), level of independence (mobility and activity), and social relationships (personal and social relationships) [<xref rid="jep70029-bib-0023" ref-type="bibr">23</xref>, <xref rid="jep70029-bib-0024" ref-type="bibr">24</xref>].</td></tr><tr><td align="left" rowspan="1" colspan="1">Patient experience</td><td align="center" rowspan="1" colspan="1">Patient&#8208;reported perception of a healthcare organisation and their journey across the continuum of care encompasses aspects such as communication, access to care, coordination of care, respect and dignity, involvement in care, physical comfort, and overall satisfaction [<xref rid="jep70029-bib-0017" ref-type="bibr">17</xref>, <xref rid="jep70029-bib-0018" ref-type="bibr">18</xref>, <xref rid="jep70029-bib-0020" ref-type="bibr">20</xref>, <xref rid="jep70029-bib-0022" ref-type="bibr">22</xref>].</td></tr><tr><td align="left" rowspan="1" colspan="1">Medication related adverse events</td><td align="center" rowspan="1" colspan="1">Negative outcomes or harmful effects that occur as a result of medication use, which could include side effects, medication errors, and any unintended consequences of medication use [<xref rid="jep70029-bib-0025" ref-type="bibr">25</xref>].</td></tr><tr><td align="left" rowspan="1" colspan="1">Medication optimisation</td><td align="center" rowspan="1" colspan="1">The systematic and comprehensive process involves maximising the benefits of medication use while minimising potential risks and adverse effects. This may involve medication additions, changes in medication intensity, discontinuation, treatment restart after discontinuation, and ensuring medication appropriateness [<xref rid="jep70029-bib-0021" ref-type="bibr">21</xref>, <xref rid="jep70029-bib-0026" ref-type="bibr">26</xref>].</td></tr><tr><td align="left" rowspan="1" colspan="1">Cost&#8208;effectiveness</td><td align="center" rowspan="1" colspan="1">Assessing the value or efficiency of a healthcare intervention or programme involves comparing the costs incurred with the outcomes achieved. This can be done using measures such as the Incremental Cost&#8208;Effectiveness Ratio (ICER) or the Incremental Cost&#8208;Utility Ratio (ICUR) [<xref rid="jep70029-bib-0019" ref-type="bibr">19</xref>, <xref rid="jep70029-bib-0021" ref-type="bibr">21</xref>, <xref rid="jep70029-bib-0027" ref-type="bibr">27</xref>, <xref rid="jep70029-bib-0028" ref-type="bibr">28</xref>].</td></tr></tbody></table><permissions><copyright-holder>John Wiley &amp; Sons, Ltd.</copyright-holder></permissions></table-wrap></sec><sec id="jep70029-sec-0110"><label>2.5</label><title>Risk of Bias and Quality Assessment</title><p>The methodological quality of each study was evaluated by two independent reviewers, A.S. and S.A., with any discrepancies resolved with the involvement of the reviewers N.W. and E.D. The Newcastle&#8208;Ottawa Scale (NOS) was utilised to assess the methodological quality of the observational studies [<xref rid="jep70029-bib-0029" ref-type="bibr">29</xref>].</p></sec></sec><sec sec-type="results" id="jep70029-sec-0120"><label>3</label><title>Results</title><p>Figure&#160;<xref rid="jep70029-fig-0001" ref-type="fig">1</xref> displays the PRISMA flow diagram of the search strategy and results. In total, 2,833 articles were identified through database searching. After removing all duplicates, 2,148 abstracts were screened for eligibility according to the predefined inclusion and exclusion criteria. In addition, 10 articles were identified by a manual search of the reference lists of retrieved journal articles. After further exclusions, 23 studies were included in the review.</p><fig position="float" fig-type="Figure" id="jep70029-fig-0001" orientation="portrait"><label>Figure 1</label><caption><p>PRISMA flow diagram of the search strategy and results.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" id="jats-graphic-1" orientation="portrait" xlink:href="JEP-31-0-g001.jpg"/></fig><sec id="jep70029-sec-0130"><label>3.1</label><title>Study Characteristics</title><p>Among the 23 included studies, 65.2% (<italic toggle="yes">n</italic>&#8201;=&#8201;15) were cohort studies, while 34.7% (<italic toggle="yes">n</italic>&#8201;=&#8201;8) were cross&#8208;sectional surveys or questionnaire&#8208;based studies. These studies involved a total of 44,472 patients, with a mean age ranging from 44 to 70 years, and males comprising a range 23%&#8211;71% of the total patient population.</p><p>In total, 51 outcome measures were used in the 23 reviewed studies. The studies examined various chronic pain conditions, with a majority focusing on mixed type of pain (<italic toggle="yes">n</italic>&#8201;=&#8201;14/23; 60.8%), followed by musculoskeletal pain (<italic toggle="yes">n</italic>&#8201;=&#8201;6/23; 26%), and a neuropathic pain (<italic toggle="yes">n</italic>&#8201;=&#8201;3/23; 13%). Additionally, among the five predefined outcomes, 39.1% of the studies (<italic toggle="yes">n</italic>&#8201;=&#8201;9/23) focused on assessing a single outcome, followed by 43.4% of studies (<italic toggle="yes">n</italic>&#8201;=&#8201;10/23) assessing two outcomes. Furthermore, 13% (<italic toggle="yes">n</italic>&#8201;=&#8201;3/23) of the studies investigated three outcomes, while only one study (4.3%) was the most comprehensive and assessed four outcomes. Treatment approaches varied among the studies, with monotherapy being used in 9 studies (39.1%), and a combination therapy approach described in 14 studies (60.8%). The most frequently investigated drugs were opioids, which were utilised in 19 studies (82.6%), followed by NSAIDs in 12 studies (52.1%).</p><p>Among the included studies, 21 (91.3%) focused on treating ongoing chronic pain, while two studies (8.6%) aimed to deprescribe treatment.</p><p>HRQoL was the main studied outcome in all 23 studies (100%). Patient experience outcomes were assessed in 7 studies (30.4%), medication&#8208;related adverse events in 6 studies (26%), and the least studied outcomes were medication optimisation and cost&#8208;effectiveness, each assessed in only three studies (13%). Additionally, the majority of tools identified were used to assess HRQoL outcomes (33 out of 51 tools; 64.7%), followed by tools used to assess patient experience (10 out of 51 tools; 19.6%).</p><p>Thirteen studies (56.5%) were conducted in primary care settings, 9 (39.1%) were conducted in hospital&#8208;based outpatient clinics, and one (4.3%) was conducted in a rehabilitation centre. These studies were conducted in 9 countries, including the USA (<italic toggle="yes">n</italic>&#8201;=&#8201;9; 39.1%); Spain (<italic toggle="yes">n</italic>&#8201;=&#8201;4; 17.4%); Canada (<italic toggle="yes">n</italic>&#8201;=&#8201;3; 13.0%); and Japan (<italic toggle="yes">n</italic>&#8201;=&#8201;2; 8.7%). One study (<italic toggle="yes">n</italic>&#8201;=&#8201;1; 4.3%) was conducted in each of Brazil, Germany, India, and the UK. Table&#160;<xref rid="jep70029-tbl-0002" ref-type="table">2</xref> presents the baseline characteristics of the included studies.</p><table-wrap position="float" id="jep70029-tbl-0002" content-type="Table" orientation="portrait"><label>Table 2</label><caption><p>Baseline characteristics of included studies (<italic toggle="yes">n</italic>&#8201;=&#8201;23).</p></caption><table frame="hsides" rules="groups"><col style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" align="left" span="1"/><col style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" align="center" span="1"/><col style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" align="center" span="1"/><col style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" align="center" span="1"/><col style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" align="center" span="1"/><col style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" align="center" span="1"/><thead><tr style="border-bottom:solid 1px #000000"><th align="left" rowspan="1" colspan="1">Author &amp; Year, Country</th><th align="center" rowspan="1" colspan="1">Study design</th><th align="center" rowspan="1" colspan="1">Population characteristics</th><th align="center" rowspan="1" colspan="1">Pain condition</th><th align="center" rowspan="1" colspan="1">Treatment used</th><th align="center" rowspan="1" colspan="1">Outcomes assessed</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Nadkarni et al., [<xref rid="jep70029-bib-0030" ref-type="bibr">30</xref>] India</td><td align="center" rowspan="1" colspan="1">Cohort</td><td align="center" rowspan="1" colspan="1">
<p>
<bold>Sample size (<italic toggle="yes">n</italic>):</bold> 100</p>
<p>
<bold>Mean (SD) age:</bold> 44.68 (12.07)</p>
<p>
<bold>Male (<italic toggle="yes">n</italic> (%)):</bold> 69 (69)</p>
<p>
<bold>Setting:</bold> Pain Specialty Outpatient at Hospital</p>
</td><td align="center" rowspan="1" colspan="1">Neuropathic pain</td><td align="center" rowspan="1" colspan="1">
<p>NSAIDs<xref rid="jep70029-tbl2-note-0001" ref-type="table-fn">a</xref>
</p>
<p>Opioids</p>
<p>TCAs<xref rid="jep70029-tbl2-note-0001" ref-type="table-fn">a</xref>
</p>
<p>Anticonvulsants</p>
</td><td align="center" rowspan="1" colspan="1">
<p>Pain improvement</p>
<p>Tolerability</p>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Robinson et al., [<xref rid="jep70029-bib-0031" ref-type="bibr">31</xref>] USA</td><td align="center" rowspan="1" colspan="1">Cross&#8208;Sectional</td><td align="center" rowspan="1" colspan="1">
<p>
<bold>Sample size (<italic toggle="yes">n</italic>):</bold> 572</p>
<p>
<bold>Mean (SD) age:</bold> 64.9 (11.3)</p>
<p>
<bold>Male (<italic toggle="yes">n</italic> (%)):</bold> 226 (39.5%)</p>
<p>
<bold>Setting:</bold> Primary care</p>
</td><td align="center" rowspan="1" colspan="1">Osteoarthritis</td><td align="center" rowspan="1" colspan="1">
<p>Paracetamol</p>
<p>NSAIDs<xref rid="jep70029-tbl2-note-0001" ref-type="table-fn">a</xref>
</p>
<p>Duloxetine</p>
<p>Opioids</p>
</td><td align="center" rowspan="1" colspan="1">
<p>Patient Satisfaction with medication</p>
<p>Patient expectation of effectiveness of medication</p>
</td></tr><tr><td align="left" rowspan="1" colspan="1">
<p>Zinboonyahgoon et al., [<xref rid="jep70029-bib-0032" ref-type="bibr">32</xref>]</p>
<p>Thailand</p>
</td><td align="center" rowspan="1" colspan="1">Cohort</td><td align="center" rowspan="1" colspan="1">
<p>
<bold>Sample size (<italic toggle="yes">n</italic>):</bold> 29</p>
<p>
<bold>Age (Median (range)):</bold> 47.4 (15&#8211;79)</p>
<p>
<bold>Male (<italic toggle="yes">n</italic> (%)):</bold> 16 (54)</p>
<p>
<bold>Setting:</bold> Pain clinic at Hospital</p>
</td><td align="center" rowspan="1" colspan="1">Chronic refractory pain</td><td align="center" rowspan="1" colspan="1">Conventional management (CMM)</td><td align="center" rowspan="1" colspan="1">
<p>Pain reduction</p>
<p>Improvement of function</p>
<p>Quality of life</p>
<p>Cost effectiveness</p>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Moreira de Barros et al., [<xref rid="jep70029-bib-0033" ref-type="bibr">33</xref>] Brazil</td><td align="center" rowspan="1" colspan="1">Cohort</td><td align="center" rowspan="1" colspan="1">
<p>
<bold>Sample size (<italic toggle="yes">n</italic>):</bold> 262</p>
<p>
<bold>Mean (SD) age:</bold> 59.2 (14.9)</p>
<p>
<bold>Male (<italic toggle="yes">n</italic> (%)):</bold> 98 (37.3)</p>
<p>
<bold>Setting:</bold> Outpatient specialised Pain Management at Hospital</p>
</td><td align="center" rowspan="1" colspan="1">Chronic pain (Nociceptive, neuropathic and mixed type)</td><td align="center" rowspan="1" colspan="1">
<p>Methadone</p>
<p>Morphine</p>
</td><td align="center" rowspan="1" colspan="1">
<p>Analgesic effect</p>
<p>Side effects</p>
<p>Pain intensity</p>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Ganguly et al., [<xref rid="jep70029-bib-0034" ref-type="bibr">34</xref>] USA</td><td align="center" rowspan="1" colspan="1">Cross&#8208;Sectional</td><td align="center" rowspan="1" colspan="1">
<p>
<bold>Sample size (<italic toggle="yes">n</italic>): 166</bold>
</p>
<p>
<bold>Mean (SD) age:</bold> &#8212;</p>
<p>
<bold>Male (<italic toggle="yes">n</italic> (%)):</bold> 108 (65)</p>
<p>
<bold>Setting:</bold> HIV primary care</p>
</td><td align="center" rowspan="1" colspan="1">Pain in HIV patients</td><td align="center" rowspan="1" colspan="1">Opioid</td><td align="center" rowspan="1" colspan="1">
<p>Satisfaction with pain management</p>
<p>Patient barriers to pain management</p>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Gudin et al., [<xref rid="jep70029-bib-0035" ref-type="bibr">35</xref>] USA</td><td align="center" rowspan="1" colspan="1">Cross&#8208;Sectional</td><td align="center" rowspan="1" colspan="1">
<p>
<bold>Sample size (n):</bold> 199</p>
<p>
<bold>Mean age:</bold> 46</p>
<p>
<bold>Male (<italic toggle="yes">n</italic> (%)):</bold> 72 (36)</p>
<p>
<bold>Setting:</bold> Outpatient clinic</p>
</td><td align="center" rowspan="1" colspan="1">Arthritis Neuropathy/radiculopathy Myofascial/musculoskeletal</td><td align="center" rowspan="1" colspan="1">
<p>OTC<xref rid="jep70029-tbl2-note-0001" ref-type="table-fn">a</xref> and prescribed NSAID<xref rid="jep70029-tbl2-note-0001" ref-type="table-fn">a</xref>
</p>
<p>Opioid</p>
<p>Anticonvulsant and</p>
<p>muscle relaxant</p>
</td><td align="center" rowspan="1" colspan="1">
<p>Pain intensity and interference</p>
<p>Patient satisfaction</p>
<p>Changes in concurrent pain medications</p>
<p>Side effect</p>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Kabor&#233; et al., [<xref rid="jep70029-bib-0036" ref-type="bibr">36</xref>] Canada</td><td align="center" rowspan="1" colspan="1">Cohort</td><td align="center" rowspan="1" colspan="1">
<p>
<bold>Sample size (<italic toggle="yes">n</italic>):</bold> 160</p>
<p>
<bold>Mean (SD) age:</bold> 51.3 (12.5)</p>
<p>
<bold>Male (<italic toggle="yes">n</italic> (%)):</bold> 49 (42.2)</p>
<p>
<bold>Setting:</bold> Pain clinic</p>
</td><td align="center" rowspan="1" colspan="1">Chronic non&#8208;cancer pain</td><td align="center" rowspan="1" colspan="1">Opioid</td><td align="center" rowspan="1" colspan="1">
<p>Pain severity</p>
<p>Quality of life</p>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Ram&#237;rez&#8208;Maestre et al., [<xref rid="jep70029-bib-0037" ref-type="bibr">37</xref>] Spain</td><td align="center" rowspan="1" colspan="1">Cross&#8208;Sectional</td><td align="center" rowspan="1" colspan="1">
<p>
<bold>Sample size (<italic toggle="yes">n</italic>):</bold> 675</p>
<p>
<bold>Mean (SD) age:</bold> 45.4 (12.9)</p>
<p>
<bold>Male (<italic toggle="yes">n</italic> (%)):</bold> 274 (41)</p>
<p>
<bold>Setting:</bold> Primary care centres</p>
</td><td align="center" rowspan="1" colspan="1">Chronic back pain</td><td align="center" rowspan="1" colspan="1">
<p>Opioids</p>
<p>Other analgesics</p>
</td><td align="center" rowspan="1" colspan="1">
<p>Pain intensity</p>
<p>Depressive symptoms</p>
<p>Pain catastrophising</p>
<p>Pain acceptance</p>
</td></tr><tr><td align="left" rowspan="1" colspan="1">
<p>Sicras&#8208;Mainar et al., [<xref rid="jep70029-bib-0038" ref-type="bibr">38</xref>]</p>
<p>Spain</p>
</td><td align="center" rowspan="1" colspan="1">Cohort</td><td align="center" rowspan="1" colspan="1">
<p>
<bold>Sample size (<italic toggle="yes">n</italic>):</bold> 38,539</p>
<p>
<bold>Mean (SD) age:</bold> 70.8 (14.3)</p>
<p>
<bold>Male (<italic toggle="yes">n</italic> (%)):</bold> 10,791 (28)</p>
<p>
<bold>Setting:</bold> Primary care centres</p>
</td><td align="center" rowspan="1" colspan="1">Osteoarthritis</td><td align="center" rowspan="1" colspan="1">
<p>Opioids</p>
<p>Other analgesics</p>
</td><td align="center" rowspan="1" colspan="1">
<p>Health/non&#8208;health resource utilisation</p>
<p>Costs</p>
<p>Treatment adherence</p>
<p>Pain change</p>
<p>Cognitive functioning</p>
<p>Dependence</p>
</td></tr><tr><td align="left" rowspan="1" colspan="1">
<p>Lee et al., [<xref rid="jep70029-bib-0039" ref-type="bibr">39</xref>]</p>
<p>USA</p>
</td><td align="center" rowspan="1" colspan="1">Cross&#8208;Sectional</td><td align="center" rowspan="1" colspan="1">
<p>
<bold>Sample size (<italic toggle="yes">n</italic>):</bold> 178</p>
<p>
<bold>Mean (SD) age:</bold> &#8212;</p>
<p>
<bold>Male (<italic toggle="yes">n</italic> (%)):</bold> &#8212;</p>
<p>
<bold>Setting:</bold> A&amp;M Health Science Centre Opioid Task Force</p>
</td><td align="center" rowspan="1" colspan="1">Chronic non&#8208;cancer pain</td><td align="center" rowspan="1" colspan="1">
<p>Narcotics</p>
<p>Non&#8208;narcotics</p>
<p>Opioids</p>
</td><td align="center" rowspan="1" colspan="1">
<p>Patient satisfaction with pain care</p>
<p>Patient satisfaction with pain relief</p>
<p>Perceptions about participation in treatment decisions</p>
<p>Confidence in physicians</p>
</td></tr><tr><td align="left" rowspan="1" colspan="1">
<p>Taguchi et al., [<xref rid="jep70029-bib-0040" ref-type="bibr">40</xref>]</p>
<p>Japan</p>
</td><td align="center" rowspan="1" colspan="1">Cohort</td><td align="center" rowspan="1" colspan="1">
<p>
<bold>Sample size (<italic toggle="yes">n</italic>):</bold> 360</p>
<p>
<bold>Mean (SD) age:</bold>
</p>
<p>Group 1: 58.3 (15.9)</p>
<p>Group 2: 66.4 (15.8)</p>
<p>
<bold>Male (<italic toggle="yes">n</italic> (%)):</bold>
</p>
<p>Group 1: 77 (53.1)</p>
<p>Group 2: 68 (30.4)</p>
<p>
<bold>Setting:</bold> Primary care</p>
</td><td align="center" rowspan="1" colspan="1">Chronic cervical radiculopathy with upper limb radiating pain</td><td align="center" rowspan="1" colspan="1">
<p>Pregabalin</p>
<p>Anticonvulsant</p>
<p>Antidepressant</p>
<p>Opioid</p>
<p>Non&#8208;opioid Analgesics</p>
</td><td align="center" rowspan="1" colspan="1">
<p>Pain related sleep interference scale</p>
<p>Pain numerical rating scale</p>
<p>Neck disability index Quality of life</p>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Wayne et al., [<xref rid="jep70029-bib-0041" ref-type="bibr">41</xref>] USA</td><td align="center" rowspan="1" colspan="1">Cohort</td><td align="center" rowspan="1" colspan="1">
<p>
<bold>Sample size (<italic toggle="yes">n</italic>):</bold> 309</p>
<p>
<bold>Mean (SD) age:</bold>
</p>
<p>Group 1: 50.18 (16.65)</p>
<p>Group 2: 52.08 (15.88)</p>
<p>
<bold>Male (<italic toggle="yes">n</italic> (%)):</bold> &#8212;</p>
<p>Group 1: 42 (31.3)</p>
<p>Group 2: 38 (26.4)</p>
<p>
<bold>Setting:</bold> Clinical Centre at hospital</p>
</td><td align="center" rowspan="1" colspan="1">Chronic back pain</td><td align="center" rowspan="1" colspan="1">Integrative or conventional care</td><td align="center" rowspan="1" colspan="1">
<p>Quality&#8208;adjusted life years (QALYs)</p>
<p>Incremental cost&#8208;effectiveness ratio (ICER)</p>
</td></tr><tr><td align="left" rowspan="1" colspan="1">McCann et al., [<xref rid="jep70029-bib-0042" ref-type="bibr">42</xref>] USA</td><td align="center" rowspan="1" colspan="1">Cohort</td><td align="center" rowspan="1" colspan="1">
<p>
<bold>Sample size (<italic toggle="yes">n</italic>):</bold> 29</p>
<p>
<bold>Mean age:</bold> 66.9</p>
<p>
<bold>Male (<italic toggle="yes">n</italic> (%)):</bold> 20 (69)</p>
<p>
<bold>Setting:</bold> Rural Primary Care Office</p>
</td><td align="center" rowspan="1" colspan="1">Nonmalignant chronic pain (neck, upper and lower back pain, shoulder, knee, polyarthralgia, peripheral neuropathy)</td><td align="center" rowspan="1" colspan="1">Opioid</td><td align="center" rowspan="1" colspan="1">
<p>Whether patients elected to remain on opioids, wean opioids, or transfer care</p>
<p>Evaluation of pain</p>
<p>Functional status</p>
<p>Mood</p>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Elsesser, Cegla [<xref rid="jep70029-bib-0043" ref-type="bibr">43</xref>] Germany</td><td align="center" rowspan="1" colspan="1">Cross&#8208;Sectional</td><td align="center" rowspan="1" colspan="1">
<p>
<bold>Sample size (<italic toggle="yes">n</italic>):</bold> 333</p>
<p>
<bold>Mean (SD) age:</bold>
</p>
<p>Group 1: 62.74 (15.34)</p>
<p>Group 2: 65.86 (13.48)</p>
<p>
<bold>Male (<italic toggle="yes">n</italic> (%)):</bold>
</p>
<p>Group 1: 24%</p>
<p>Group 2: 26.5%</p>
<p>
<bold>Setting:</bold> Clinic for Pain Medicine in primary care</p>
</td><td align="center" rowspan="1" colspan="1">Non&#8208;cancer chronic pain including neuropathic pain</td><td align="center" rowspan="1" colspan="1">
<p>Opioids</p>
<p>Analgesics</p>
<p>Coanalgesics</p>
</td><td align="center" rowspan="1" colspan="1">
<p>Pain</p>
<p>Functional disability</p>
<p>Psychological wellbeing</p>
<p>Quality of life</p>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Ghodke et al., [<xref rid="jep70029-bib-0044" ref-type="bibr">44</xref>] USA</td><td align="center" rowspan="1" colspan="1">Cohort</td><td align="center" rowspan="1" colspan="1">
<p>
<bold>Sample size (<italic toggle="yes">n</italic>):</bold> 171</p>
<p>
<bold>Mean (SD) age:</bold>
</p>
<p>Group 1: 59.6 (10.32)</p>
<p>Group 2: 59.9 (8.83)</p>
<p>
<bold>Male (<italic toggle="yes">n</italic> (%)):</bold> 54 (31.5)</p>
<p>
<bold>Setting:</bold> Internal Medicine Pain Service</p>
</td><td align="center" rowspan="1" colspan="1">Moderate to severe osteoarthritis</td><td align="center" rowspan="1" colspan="1">Opioid</td><td align="center" rowspan="1" colspan="1">
<p>Average pain scores</p>
<p>Lowest pain scores</p>
<p>Morphine equivalence</p>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Vogler et al., [<xref rid="jep70029-bib-0045" ref-type="bibr">45</xref>] USA</td><td align="center" rowspan="1" colspan="1">Cohort</td><td align="center" rowspan="1" colspan="1">
<p>
<bold>Sample size (<italic toggle="yes">n</italic>):</bold> 35</p>
<p>
<bold>Mean (SD) age:</bold> 58 (11)</p>
<p>
<bold>Male (%):</bold> 23%</p>
<p>
<bold>Setting:</bold> Primary care clinic</p>
</td><td align="center" rowspan="1" colspan="1">Chronic non&#8208;cancer pain (Back pain, upper and lower extremity pain, neck pain)</td><td align="center" rowspan="1" colspan="1">Opioid</td><td align="center" rowspan="1" colspan="1">
<p>Functional Status</p>
<p>Knowledge</p>
<p>Behaviour</p>
<p>Satisfaction</p>
</td></tr><tr><td align="left" rowspan="1" colspan="1">
<p>White et al., [<xref rid="jep70029-bib-0046" ref-type="bibr">46</xref>]</p>
<p>Canada</p>
</td><td align="center" rowspan="1" colspan="1">Cross&#8208;Sectional</td><td align="center" rowspan="1" colspan="1">
<p>
<bold>Sample size (<italic toggle="yes">n</italic>):</bold> 102</p>
<p>
<bold>Mean (SD) age:</bold> 45.9 (11.7)</p>
<p>
<bold>Male (<italic toggle="yes">n</italic> (%)):</bold> 57 (55.9)</p>
<p>
<bold>Setting:</bold> Rehabilitation centre</p>
</td><td align="center" rowspan="1" colspan="1">
<p>Myofascial pain</p>
<p>Other musculoskeletal pain</p>
<p>Neuropathic pain,</p>
<p>Mixed pain,</p>
<p>Psychological diagnoses (pain disorder)</p>
<p>Complex regional pain syndrome</p>
</td><td align="center" rowspan="1" colspan="1">Opioid</td><td align="center" rowspan="1" colspan="1">
<p>Pain interference</p>
<p>Pain severity</p>
<p>Depression</p>
<p>Opioid intake</p>
</td></tr><tr><td align="left" rowspan="1" colspan="1">
<p>Igarashi et al., [<xref rid="jep70029-bib-0047" ref-type="bibr">47</xref>]</p>
<p>Japan</p>
</td><td align="center" rowspan="1" colspan="1">Cohort Study</td><td align="center" rowspan="1" colspan="1">
<p>
<bold>Sample size (<italic toggle="yes">n</italic>):</bold> 331</p>
<p>
<bold>Mean age (Mean (SD)):</bold> 60</p>
<p>
<bold>Male (<italic toggle="yes">n</italic> (%)):</bold> &#8212;</p>
<p>
<bold>Setting:</bold> Primary care clinic</p>
</td><td align="center" rowspan="1" colspan="1">Chronic low back pain with accompanying neuropathic pain</td><td align="center" rowspan="1" colspan="1">Pregabalin</td><td align="center" rowspan="1" colspan="1">
<p>Quality&#8208;adjusted life years (QALYs)</p>
<p>Direct medical costs</p>
<p>Hospitalisation costs</p>
<p>Productivity losses</p>
</td></tr><tr><td align="left" rowspan="1" colspan="1">
<p>Dunn et al., [<xref rid="jep70029-bib-0048" ref-type="bibr">48</xref>]</p>
<p>USA</p>
</td><td align="center" rowspan="1" colspan="1">Cross&#8208;Sectional Study</td><td align="center" rowspan="1" colspan="1">
<p>
<bold>Sample size (<italic toggle="yes">n</italic>):</bold> 227</p>
<p>
<bold>Mean age (Mean (SEM)):</bold> 46.00 (0.87)</p>
<p>
<bold>Male (<italic toggle="yes">n</italic> (%)):</bold> 64 (47)</p>
<p>
<bold>Setting:</bold> Addiction treatment clinic</p>
</td><td align="center" rowspan="1" colspan="1">Upper and lower extremities back, head, neck, shoulders, chest, abdomen and hips pain</td><td align="center" rowspan="1" colspan="1">
<p>Opioid</p>
<p>Ibuprofen</p>
<p>Gabapentin</p>
</td><td align="center" rowspan="1" colspan="1">Pain intensity</td></tr><tr><td align="left" rowspan="1" colspan="1">
<p>Jouini et al., [<xref rid="jep70029-bib-0049" ref-type="bibr">49</xref>]</p>
<p>Canada</p>
</td><td align="center" rowspan="1" colspan="1">Cohort Study</td><td align="center" rowspan="1" colspan="1">
<p>
<bold>Sample size (<italic toggle="yes">n</italic>):</bold> 486</p>
<p>
<bold>Mean age (Mean (SD)):</bold> 58.4 (12.5)</p>
<p>
<bold>Male (<italic toggle="yes">n</italic> (%)):</bold> 157 (32.3)</p>
<p>
<bold>Setting:</bold> Primary care clinic</p>
</td><td align="center" rowspan="1" colspan="1">
<p>Osteoarthritis and other osteopathologie</p>
<p>Chronic back pain</p>
<p>Chronic neck pain</p>
<p>Fibromyalgia</p>
<p>Tendinitis, bursitis, capsulitis, epicondylitis</p>
</td><td align="center" rowspan="1" colspan="1">
<p>Paracetamol</p>
<p>NSAIDs<xref rid="jep70029-tbl2-note-0001" ref-type="table-fn">a</xref>
</p>
<p>Anticonvulsants</p>
<p>Antidepressants</p>
<p>Muscle relaxants</p>
<p>Opioids</p>
</td><td align="center" rowspan="1" colspan="1">
<p>Pain intensity</p>
<p>Emotional wellbeing</p>
<p>Satisfaction with pain treatment</p>
<p>Barriers/beliefs/attitudes about pain and its treatment</p>
</td></tr><tr><td align="left" rowspan="1" colspan="1">
<p>Ashworth et al., [<xref rid="jep70029-bib-0050" ref-type="bibr">50</xref>]</p>
<p>UK</p>
</td><td align="center" rowspan="1" colspan="1">Cohort Study</td><td align="center" rowspan="1" colspan="1">
<p>
<bold>Sample size (<italic toggle="yes">n</italic>):</bold> 715</p>
<p>
<bold>Mean age (Mean (SD)):</bold>
</p>
<p>Group 1: 45.77 (9.87)</p>
<p>Group 2: 46.27 (9.36)</p>
<p>Group 3: 44.07 (10.69)</p>
<p>Group 4: 47.64 (9.39)</p>
<p>
<bold>Male (<italic toggle="yes">n</italic> (%)):</bold>
</p>
<p>Group 1: 44%</p>
<p>Group 2: 33%</p>
<p>Group 3: 27%</p>
<p>Group 4: 24%</p>
<p>
<bold>Setting:</bold> UK primary care</p>
</td><td align="center" rowspan="1" colspan="1">Chronic lower back pain</td><td align="center" rowspan="1" colspan="1">Opioid</td><td align="center" rowspan="1" colspan="1">Disability</td></tr><tr><td align="left" rowspan="1" colspan="1">
<p>P&#233;rez et al., [<xref rid="jep70029-bib-0051" ref-type="bibr">51</xref>]</p>
<p>Spain</p>
</td><td align="center" rowspan="1" colspan="1">Cohort Study</td><td align="center" rowspan="1" colspan="1">
<p>
<bold>Sample size (<italic toggle="yes">n</italic>):</bold> 1,845</p>
<p>
<bold>Mean age (Mean (SD)):</bold>
</p>
<p>Group 1: 58.6 (12.5)</p>
<p>Group 2: 59.7 (13.0)</p>
<p>Group 3: 60.4 (12.4)</p>
<p>
<bold>Male (<italic toggle="yes">n</italic> (%)):</bold>
</p>
<p>Group 1: 289 (39.6)</p>
<p>Group 2: 307 (42.2)</p>
<p>Group 3: 84 (44.7)</p>
<p>
<bold>Setting:</bold> Primary care clinic</p>
</td><td align="center" rowspan="1" colspan="1">Neuropathic pain</td><td align="center" rowspan="1" colspan="1">
<p>Pregabalin</p>
<p>Analgesics</p>
</td><td align="center" rowspan="1" colspan="1">
<p>Pain intensity</p>
<p>Disability</p>
<p>Sleep disturbances</p>
<p>Anxiety and depression</p>
<p>Quality of life</p>
<p>Health care resource utilisation</p>
<p>Corresponding costs</p>
</td></tr><tr><td align="left" rowspan="1" colspan="1">
<p>Blanco Tarrio et al., [<xref rid="jep70029-bib-0052" ref-type="bibr">52</xref>]</p>
<p>Spain</p>
</td><td align="center" rowspan="1" colspan="1">Cohort Study</td><td align="center" rowspan="1" colspan="1">
<p>
<bold>Sample size (<italic toggle="yes">n</italic>):</bold> 1,670</p>
<p>
<bold>Mean age (Mean (SD)):</bold> 58.5 (13.7)</p>
<p>
<bold>Male (<italic toggle="yes">n</italic> (%)):</bold> 689 (41)</p>
<p>
<bold>Setting:</bold> Spanish primary care</p>
</td><td align="center" rowspan="1" colspan="1">Neuropathic pain</td><td align="center" rowspan="1" colspan="1">
<p>Pregabalin</p>
<p>Anticonvulsant</p>
<p>Antidepressant</p>
<p>Opioid</p>
<p>Non&#8208;opioid analgesics</p>
</td><td align="center" rowspan="1" colspan="1">
<p>Pain Intensity</p>
<p>Interference of pain with activities</p>
<p>Number of days with no or mild pain</p>
<p>Treatment satisfaction</p>
</td></tr></tbody></table><table-wrap-foot><fn id="jep70029-tbl2-note-0001"><label>
<sup>a</sup>
</label><p>Abbreviations: NSAIDs &#8208; Nonsteroidal anti&#8208;inflammatory drugs; OTC &#8208; Over the counter; TCAs &#8208; Tricyclic antidepressants;</p></fn></table-wrap-foot><permissions><copyright-holder>John Wiley &amp; Sons, Ltd.</copyright-holder></permissions></table-wrap><sec id="jep70029-sec-0140"><label>3.1.1</label><title>Quality Assessment</title><p>Table&#160;<xref rid="jep70029-tbl-0003" ref-type="table">3</xref> presents the quality assessment results for the included studies using the NOS approach. Among the 15 cohort studies, 13 were classified as high quality, and three studies were rated as moderate quality. For the 8 cross&#8208;sectional studies, 7 achieved high quality, while one study was deemed of moderate quality.</p><table-wrap position="float" id="jep70029-tbl-0003" content-type="Table" orientation="portrait"><label>Table 3</label><caption><p>Summary result of risk of bias and Quality assessment.</p></caption><table frame="hsides" rules="groups"><col style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" align="left" span="1"/><col style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" align="center" span="1"/><col style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" align="center" span="1"/><col style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" align="center" span="1"/><col style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" align="center" span="1"/><thead><tr style="border-bottom:solid 1px #000000"><th align="left" rowspan="1" colspan="1">Study ID (ref)</th><th align="center" rowspan="1" colspan="1">Selection (Max 4 stars)</th><th align="center" rowspan="1" colspan="1">Comparability (Max 2 stars)</th><th align="center" rowspan="1" colspan="1">Outcome (Max 3 stars)</th><th align="center" rowspan="1" colspan="1">Score out of 9 (Quality rating)<xref rid="jep70029-tbl3-note-0001" ref-type="table-fn">a</xref>
</th></tr></thead><tbody valign="top"><tr><td align="left" colspan="5" valign="top" rowspan="1">
<bold>Modified NOS for cross&#8208;sectional studies</bold>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Robinson et al., [<xref rid="jep70029-bib-0031" ref-type="bibr">31</xref>]</td><td align="center" valign="top" rowspan="1" colspan="1">***</td><td align="center" valign="top" rowspan="1" colspan="1">*</td><td align="center" valign="top" rowspan="1" colspan="1">***</td><td align="center" valign="top" rowspan="1" colspan="1">7 (High)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Ganguly et al., [<xref rid="jep70029-bib-0034" ref-type="bibr">34</xref>]</td><td align="center" valign="top" rowspan="1" colspan="1">**</td><td align="center" valign="top" rowspan="1" colspan="1">**</td><td align="center" valign="top" rowspan="1" colspan="1">***</td><td align="center" valign="top" rowspan="1" colspan="1">7 (High)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Gudin et al., [<xref rid="jep70029-bib-0035" ref-type="bibr">35</xref>]</td><td align="center" valign="top" rowspan="1" colspan="1">***</td><td align="center" valign="top" rowspan="1" colspan="1">*</td><td align="center" valign="top" rowspan="1" colspan="1">***</td><td align="center" valign="top" rowspan="1" colspan="1">7 (High)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Ram&#237;rez&#8208;Maestre et al., [<xref rid="jep70029-bib-0037" ref-type="bibr">37</xref>]</td><td align="center" valign="top" rowspan="1" colspan="1">****</td><td align="center" valign="top" rowspan="1" colspan="1">**</td><td align="center" valign="top" rowspan="1" colspan="1">***</td><td align="center" valign="top" rowspan="1" colspan="1">9 (High)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Lee et al., [<xref rid="jep70029-bib-0039" ref-type="bibr">39</xref>]</td><td align="center" valign="top" rowspan="1" colspan="1">***</td><td align="center" valign="top" rowspan="1" colspan="1">**</td><td align="center" valign="top" rowspan="1" colspan="1">***</td><td align="center" valign="top" rowspan="1" colspan="1">8 (High)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Elsesser, Cegla [<xref rid="jep70029-bib-0043" ref-type="bibr">43</xref>]</td><td align="center" valign="top" rowspan="1" colspan="1">***</td><td align="center" valign="top" rowspan="1" colspan="1">**</td><td align="center" valign="top" rowspan="1" colspan="1">***</td><td align="center" valign="top" rowspan="1" colspan="1">8 (High)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">White et al., [<xref rid="jep70029-bib-0046" ref-type="bibr">46</xref>]</td><td align="center" valign="top" rowspan="1" colspan="1">**</td><td align="center" valign="top" rowspan="1" colspan="1">**</td><td align="center" valign="top" rowspan="1" colspan="1">**</td><td align="center" valign="top" rowspan="1" colspan="1">6 (Moderate)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Dunn et al., [<xref rid="jep70029-bib-0048" ref-type="bibr">48</xref>]</td><td align="center" valign="top" rowspan="1" colspan="1">***</td><td align="center" valign="top" rowspan="1" colspan="1">**</td><td align="center" valign="top" rowspan="1" colspan="1">***</td><td align="center" valign="top" rowspan="1" colspan="1">8 (High)</td></tr><tr><td align="left" colspan="5" valign="top" rowspan="1">
<bold>NOS for cohort studies</bold>
</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Nadkarni et al., [<xref rid="jep70029-bib-0030" ref-type="bibr">30</xref>]</td><td align="center" valign="top" rowspan="1" colspan="1">****</td><td align="center" valign="top" rowspan="1" colspan="1">**</td><td align="center" valign="top" rowspan="1" colspan="1">**</td><td align="center" valign="top" rowspan="1" colspan="1">8 (High)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Zinboonyahgoon et al., [<xref rid="jep70029-bib-0032" ref-type="bibr">32</xref>]</td><td align="center" valign="top" rowspan="1" colspan="1">***</td><td align="center" valign="top" rowspan="1" colspan="1">*</td><td align="center" valign="top" rowspan="1" colspan="1">***</td><td align="center" valign="top" rowspan="1" colspan="1">7 (High)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Moreira de Barros et al., [<xref rid="jep70029-bib-0033" ref-type="bibr">33</xref>]</td><td align="center" valign="top" rowspan="1" colspan="1">**</td><td align="center" valign="top" rowspan="1" colspan="1">**</td><td align="center" valign="top" rowspan="1" colspan="1">***</td><td align="center" valign="top" rowspan="1" colspan="1">7 (High)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Kabor&#233; et al., [<xref rid="jep70029-bib-0036" ref-type="bibr">36</xref>]</td><td align="center" valign="top" rowspan="1" colspan="1">***</td><td align="center" valign="top" rowspan="1" colspan="1">**</td><td align="center" valign="top" rowspan="1" colspan="1">**</td><td align="center" valign="top" rowspan="1" colspan="1">7 (High)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Sicras&#8208;Mainar et al., [<xref rid="jep70029-bib-0038" ref-type="bibr">38</xref>]</td><td align="center" valign="top" rowspan="1" colspan="1">***</td><td align="center" valign="top" rowspan="1" colspan="1">**</td><td align="center" valign="top" rowspan="1" colspan="1">***</td><td align="center" valign="top" rowspan="1" colspan="1">8 (High)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Taguchi et al., [<xref rid="jep70029-bib-0040" ref-type="bibr">40</xref>]</td><td align="center" valign="top" rowspan="1" colspan="1">***</td><td align="center" valign="top" rowspan="1" colspan="1">**</td><td align="center" valign="top" rowspan="1" colspan="1">***</td><td align="center" valign="top" rowspan="1" colspan="1">8 (High)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Wayne et al., [<xref rid="jep70029-bib-0041" ref-type="bibr">41</xref>]</td><td align="center" valign="top" rowspan="1" colspan="1">***</td><td align="center" valign="top" rowspan="1" colspan="1">**</td><td align="center" valign="top" rowspan="1" colspan="1">**</td><td align="center" valign="top" rowspan="1" colspan="1">7 (High)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">McCann et al., [<xref rid="jep70029-bib-0042" ref-type="bibr">42</xref>]</td><td align="center" valign="top" rowspan="1" colspan="1">***</td><td align="center" valign="top" rowspan="1" colspan="1">**</td><td align="center" valign="top" rowspan="1" colspan="1">**</td><td align="center" valign="top" rowspan="1" colspan="1">7 (High)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Ghodke et al., [<xref rid="jep70029-bib-0044" ref-type="bibr">44</xref>]</td><td align="center" valign="top" rowspan="1" colspan="1">***</td><td align="center" valign="top" rowspan="1" colspan="1">*</td><td align="center" valign="top" rowspan="1" colspan="1">**</td><td align="center" valign="top" rowspan="1" colspan="1">6 (Moderate)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Vogler et al., [<xref rid="jep70029-bib-0045" ref-type="bibr">45</xref>]</td><td align="center" valign="top" rowspan="1" colspan="1">**</td><td align="center" valign="top" rowspan="1" colspan="1">&#8212;</td><td align="center" valign="top" rowspan="1" colspan="1">***</td><td align="center" valign="top" rowspan="1" colspan="1">5 (Moderate)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Igarashi et al., [<xref rid="jep70029-bib-0047" ref-type="bibr">47</xref>]</td><td align="center" valign="top" rowspan="1" colspan="1">***</td><td align="center" valign="top" rowspan="1" colspan="1">**</td><td align="center" valign="top" rowspan="1" colspan="1">***</td><td align="center" valign="top" rowspan="1" colspan="1">8 (High)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Jouini et al., [<xref rid="jep70029-bib-0049" ref-type="bibr">49</xref>]</td><td align="center" valign="top" rowspan="1" colspan="1">**</td><td align="center" valign="top" rowspan="1" colspan="1">*</td><td align="center" valign="top" rowspan="1" colspan="1">**</td><td align="center" valign="top" rowspan="1" colspan="1">5 (Moderate)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Ashworth et al., [<xref rid="jep70029-bib-0050" ref-type="bibr">50</xref>]</td><td align="center" valign="top" rowspan="1" colspan="1">***</td><td align="center" valign="top" rowspan="1" colspan="1">**</td><td align="center" valign="top" rowspan="1" colspan="1">**</td><td align="center" valign="top" rowspan="1" colspan="1">7 (High)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">P&#233;rez et al., [<xref rid="jep70029-bib-0051" ref-type="bibr">51</xref>]</td><td align="center" valign="top" rowspan="1" colspan="1">***</td><td align="center" valign="top" rowspan="1" colspan="1">**</td><td align="center" valign="top" rowspan="1" colspan="1">***</td><td align="center" valign="top" rowspan="1" colspan="1">8 (High)</td></tr><tr><td align="left" valign="top" rowspan="1" colspan="1">Blanco Tarrio et al., [<xref rid="jep70029-bib-0052" ref-type="bibr">52</xref>]</td><td align="center" valign="top" rowspan="1" colspan="1">***</td><td align="center" valign="top" rowspan="1" colspan="1">**</td><td align="center" valign="top" rowspan="1" colspan="1">***</td><td align="center" valign="top" rowspan="1" colspan="1">8 (High)</td></tr></tbody></table><table-wrap-foot><fn id="jep70029-tbl3-note-0001"><label>
<sup>a</sup>
</label><p>The quality assessment scores range from 0 to 9 stars, where 7 or more stars indicate high quality, 4 to 6 stars indicate moderate quality, and 1 to 3 stars indicate low quality.</p></fn></table-wrap-foot><permissions><copyright-holder>John Wiley &amp; Sons, Ltd.</copyright-holder></permissions></table-wrap></sec></sec><sec id="jep70029-sec-0150"><label>3.2</label><title>Analysis of the Outcome Measures</title><p>The tools used were inadequately described (e.g., frequency of use, reasons for selection) in 60.8% of the studies (<italic toggle="yes">n</italic>&#8201;=&#8201;14/23). A measurement tool was considered validated if the study confirmed the validation of the tool in their study process, regardless of its quality and the disease entity studied. Tables&#160;<xref rid="jep70029-tbl-0004" ref-type="table">4</xref>, <xref rid="jep70029-tbl-0005" ref-type="table">5</xref>, <xref rid="jep70029-tbl-0006" ref-type="table">6</xref>, <xref rid="jep70029-tbl-0007" ref-type="table">7</xref>, <xref rid="jep70029-tbl-0008" ref-type="table">8</xref> presents the identified outcome measures and their usage frequencies in the included studies. Additionally, Figure&#160;<xref rid="jep70029-fig-0002" ref-type="fig">2</xref> displays the most utilised tool across all identified domains.</p><table-wrap position="float" id="jep70029-tbl-0004" content-type="Table" orientation="portrait"><label>Table 4</label><caption><p>HRQoL outcome measure tools identified and their usage frequencies in the included studies (<italic toggle="yes">n</italic>&#8201;=&#8201;23).</p></caption><table frame="hsides" rules="groups"><col style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" align="left" span="1"/><col style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" align="center" span="1"/><col style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" align="center" span="1"/><col style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" align="center" span="1"/><thead><tr style="border-bottom:solid 1px #000000"><th align="left" rowspan="1" colspan="1">Domains</th><th align="center" rowspan="1" colspan="1">Subdomain (s)</th><th align="center" rowspan="1" colspan="1">Tools</th><th align="center" rowspan="1" colspan="1">
<italic toggle="yes">N</italic> (%)</th></tr></thead><tbody><tr><td rowspan="8" align="left" colspan="1">Physical health</td><td rowspan="3" align="center" colspan="1">Pain intensity</td><td align="center" rowspan="1" colspan="1">
<p>Numerical pain rating scale (NPRS) [<xref rid="jep70029-bib-0031" ref-type="bibr">31</xref>, <xref rid="jep70029-bib-0038" ref-type="bibr">38</xref>, <xref rid="jep70029-bib-0043" ref-type="bibr">43</xref>, <xref rid="jep70029-bib-0046" ref-type="bibr">46</xref>, <xref rid="jep70029-bib-0047" ref-type="bibr">47</xref>, <xref rid="jep70029-bib-0049" ref-type="bibr">49</xref>, <xref rid="jep70029-bib-0050" ref-type="bibr">50</xref>]</p>
</td><td align="center" rowspan="1" colspan="1">7 (30.4)</td></tr><tr><td align="center" rowspan="1" colspan="1">
<p>Short&#8208;Form McGill Pain Questionnaire [<xref rid="jep70029-bib-0030" ref-type="bibr">30</xref>, <xref rid="jep70029-bib-0051" ref-type="bibr">51</xref>]</p>
</td><td align="center" rowspan="1" colspan="1">2 (8.6)</td></tr><tr><td align="center" rowspan="1" colspan="1">11&#8208;point numeric verbal scale [<xref rid="jep70029-bib-0033" ref-type="bibr">33</xref>]</td><td align="center" rowspan="1" colspan="1">1 (4.3)</td></tr><tr><td rowspan="2" align="center" colspan="1">Pain intensity (neuropathic pain)</td><td align="center" rowspan="1" colspan="1">
<p>Neuropathic 4 Pain Questions (DN4) [<xref rid="jep70029-bib-0036" ref-type="bibr">36</xref>, <xref rid="jep70029-bib-0052" ref-type="bibr">52</xref>]</p>
</td><td align="center" rowspan="1" colspan="1">2 (8.6)</td></tr><tr><td align="center" rowspan="1" colspan="1">PainDETECT questionnaire [<xref rid="jep70029-bib-0043" ref-type="bibr">43</xref>]</td><td align="center" rowspan="1" colspan="1">1 (4.3)</td></tr><tr><td rowspan="3" align="center" colspan="1">Sleep and rest</td><td align="center" rowspan="1" colspan="1">Pain&#8208;Related Sleep&#8208;Interference Scale (PRSIS) [<xref rid="jep70029-bib-0040" ref-type="bibr">40</xref>, <xref rid="jep70029-bib-0047" ref-type="bibr">47</xref>]</td><td align="center" rowspan="1" colspan="1">2 (8.6)</td></tr><tr><td align="center" rowspan="1" colspan="1">Medical Outcomes Study Sleep Scale (MOS&#8208;Sleep) [<xref rid="jep70029-bib-0051" ref-type="bibr">51</xref>]</td><td align="center" rowspan="1" colspan="1">1 (4.3)</td></tr><tr><td align="center" rowspan="1" colspan="1">Chronic Pain Sleep Inventory [<xref rid="jep70029-bib-0049" ref-type="bibr">49</xref>]</td><td align="center" rowspan="1" colspan="1">1 (4.3)</td></tr><tr><td rowspan="7" align="left" colspan="1">Psychological health</td><td rowspan="7" align="center" colspan="1">Cognitive and emotional response to pain</td><td align="center" rowspan="1" colspan="1">
<p>Hospital Anxiety and Depression Scale (HADS) [<xref rid="jep70029-bib-0037" ref-type="bibr">37</xref>, <xref rid="jep70029-bib-0043" ref-type="bibr">43</xref>, <xref rid="jep70029-bib-0049" ref-type="bibr">49</xref>, <xref rid="jep70029-bib-0050" ref-type="bibr">50</xref>, <xref rid="jep70029-bib-0051" ref-type="bibr">51</xref>]</p>
</td><td align="center" rowspan="1" colspan="1">5 (21.7)</td></tr><tr><td align="center" rowspan="1" colspan="1">Beck Depression Inventory&#8208;I (BDI)[<xref rid="jep70029-bib-0036" ref-type="bibr">36</xref>, <xref rid="jep70029-bib-0046" ref-type="bibr">46</xref>]</td><td align="center" rowspan="1" colspan="1">2 (8.6)</td></tr><tr><td align="center" rowspan="1" colspan="1">Pain Catastrophising Scale (PCS) [<xref rid="jep70029-bib-0036" ref-type="bibr">36</xref>, <xref rid="jep70029-bib-0037" ref-type="bibr">37</xref>]</td><td align="center" rowspan="1" colspan="1">2 (8.6)</td></tr><tr><td align="center" rowspan="1" colspan="1">Zung Depression scale [<xref rid="jep70029-bib-0042" ref-type="bibr">42</xref>]</td><td align="center" rowspan="1" colspan="1">1 (4.3)</td></tr><tr><td align="center" rowspan="1" colspan="1">Tampa Scale of Kinesiophobia [<xref rid="jep70029-bib-0050" ref-type="bibr">50</xref>]</td><td align="center" rowspan="1" colspan="1">1 (4.3)</td></tr><tr><td align="center" rowspan="1" colspan="1">Mini&#8208;Mental State Examination (MMSE) [<xref rid="jep70029-bib-0038" ref-type="bibr">38</xref>]</td><td align="center" rowspan="1" colspan="1">1 (4.3)</td></tr><tr><td align="center" rowspan="1" colspan="1">Chronic Pain Acceptance Questionnaire (CPAQ&#8208;SV) [<xref rid="jep70029-bib-0037" ref-type="bibr">37</xref>]</td><td align="center" rowspan="1" colspan="1">1 (4.3)</td></tr><tr><td rowspan="8" align="left" colspan="1">Level of dependence</td><td rowspan="5" align="center" colspan="1">Performance status and disability</td><td align="center" rowspan="1" colspan="1">Karnofsky Performance Status [<xref rid="jep70029-bib-0033" ref-type="bibr">33</xref>]</td><td align="center" rowspan="1" colspan="1">1 (4.3)</td></tr><tr><td align="center" rowspan="1" colspan="1">The modified Pain Disability Index (mPDI) [<xref rid="jep70029-bib-0043" ref-type="bibr">43</xref>]</td><td align="center" rowspan="1" colspan="1">1 (4.3)</td></tr><tr><td align="center" rowspan="1" colspan="1">Pain Self&#8208;Efficacy Questionnaire [<xref rid="jep70029-bib-0050" ref-type="bibr">50</xref>]</td><td align="center" rowspan="1" colspan="1">1 (4.3)</td></tr><tr><td align="center" rowspan="1" colspan="1">Physical Function subscale [<xref rid="jep70029-bib-0031" ref-type="bibr">31</xref>]</td><td align="center" rowspan="1" colspan="1">1 (4.3)</td></tr><tr><td align="center" rowspan="1" colspan="1">Barthel index [<xref rid="jep70029-bib-0038" ref-type="bibr">38</xref>]</td><td align="center" rowspan="1" colspan="1">1 (4.3)</td></tr><tr><td rowspan="2" align="center" colspan="1">Back pain&#8208;related functional limitation</td><td align="center" rowspan="1" colspan="1">Roland&#8208;Morris Disability Questionnaire [RMDQ] [<xref rid="jep70029-bib-0041" ref-type="bibr">41</xref>, <xref rid="jep70029-bib-0042" ref-type="bibr">42</xref>, <xref rid="jep70029-bib-0050" ref-type="bibr">50</xref>]</td><td align="center" rowspan="1" colspan="1">3 (13.0)</td></tr><tr><td align="center" rowspan="1" colspan="1">Oswestry Disability Index Survey [<xref rid="jep70029-bib-0045" ref-type="bibr">45</xref>]</td><td align="center" rowspan="1" colspan="1">1 (4.3)</td></tr><tr><td align="center" rowspan="1" colspan="1">Neck pain&#8208;related functional limitation</td><td align="center" rowspan="1" colspan="1">Neck Disability Index (NDI) [<xref rid="jep70029-bib-0040" ref-type="bibr">40</xref>]</td><td align="center" rowspan="1" colspan="1">1 (4.3)</td></tr><tr><td align="left" rowspan="1" colspan="1">Social relationships</td><td align="center" rowspan="1" colspan="1">Social life and responsibilities</td><td align="center" rowspan="1" colspan="1">Sheehan Disability Inventory (SDI) [<xref rid="jep70029-bib-0051" ref-type="bibr">51</xref>]</td><td align="center" rowspan="1" colspan="1">1 (4.3)</td></tr><tr><td rowspan="9" align="left" colspan="1">Tools assessing multiple domains of HRQoL</td><td align="center" rowspan="1" colspan="1">Assess pain intensity and impact on daily activities</td><td align="center" rowspan="1" colspan="1">The Brief Pain Inventory (BPI) [<xref rid="jep70029-bib-0034" ref-type="bibr">34</xref>, <xref rid="jep70029-bib-0035" ref-type="bibr">35</xref>, <xref rid="jep70029-bib-0036" ref-type="bibr">36</xref>, <xref rid="jep70029-bib-0042" ref-type="bibr">42</xref>, <xref rid="jep70029-bib-0044" ref-type="bibr">44</xref>, <xref rid="jep70029-bib-0046" ref-type="bibr">46</xref>, <xref rid="jep70029-bib-0048" ref-type="bibr">48</xref>, <xref rid="jep70029-bib-0049" ref-type="bibr">49</xref>, <xref rid="jep70029-bib-0051" ref-type="bibr">51</xref>]</td><td align="center" rowspan="1" colspan="1">9 (39.1)</td></tr><tr><td align="center" rowspan="1" colspan="1">Mobility, self&#8208;care, usual activities, pain/discomfort, and anxiety/depression</td><td align="center" rowspan="1" colspan="1">European Quality of Life&#8208;5 Dimensions (EQ&#8208;5D) [<xref rid="jep70029-bib-0031" ref-type="bibr">31</xref>, <xref rid="jep70029-bib-0032" ref-type="bibr">32</xref>, <xref rid="jep70029-bib-0040" ref-type="bibr">40</xref>, <xref rid="jep70029-bib-0047" ref-type="bibr">47</xref>, <xref rid="jep70029-bib-0051" ref-type="bibr">51</xref>]</td><td align="center" rowspan="1" colspan="1">5 (21.7)</td></tr><tr><td align="center" rowspan="1" colspan="1">Physical and mental health functioning</td><td align="center" rowspan="1" colspan="1">Short Form&#8208;12 Health Survey (SF&#8208;12v2) [<xref rid="jep70029-bib-0036" ref-type="bibr">36</xref>, <xref rid="jep70029-bib-0041" ref-type="bibr">41</xref>]</td><td align="center" rowspan="1" colspan="1">2 (8.6)</td></tr><tr><td align="center" rowspan="1" colspan="1">Pain intensity, enjoyment of life, and general activity</td><td align="center" rowspan="1" colspan="1">Pain Intensity, Enjoyment of life, and General Activity (PEG) score [<xref rid="jep70029-bib-0036" ref-type="bibr">36</xref>, <xref rid="jep70029-bib-0045" ref-type="bibr">45</xref>]</td><td align="center" rowspan="1" colspan="1">2 (8.6)</td></tr><tr><td align="center" rowspan="1" colspan="1">Physical health, psychological health, social relationships, and environment</td><td align="center" rowspan="1" colspan="1">World Health Organisation Quality of Life&#8208; Brief Version (WHOQoL&#8208;BREF) [<xref rid="jep70029-bib-0043" ref-type="bibr">43</xref>]</td><td align="center" rowspan="1" colspan="1">1 (4.3)</td></tr><tr><td align="center" rowspan="1" colspan="1">Pain intensity, impact on daily activities, mood, and sleep</td><td align="center" rowspan="1" colspan="1">German Pain Questionnaire (GPQ) [<xref rid="jep70029-bib-0043" ref-type="bibr">43</xref>]</td><td align="center" rowspan="1" colspan="1">1 (4.3)</td></tr><tr><td align="center" rowspan="1" colspan="1">Pain intensity and disability</td><td align="center" rowspan="1" colspan="1">Chronic Pain Grade Scale (CPG) [<xref rid="jep70029-bib-0043" ref-type="bibr">43</xref>]</td><td align="center" rowspan="1" colspan="1">1 (4.3)</td></tr><tr><td align="center" rowspan="1" colspan="1">Pain intensity, physical function, and emotional wellbeing</td><td align="center" rowspan="1" colspan="1">American Pain Society Patient Outcome Questionnaire [<xref rid="jep70029-bib-0039" ref-type="bibr">39</xref>]</td><td align="center" rowspan="1" colspan="1">1 (4.3)</td></tr><tr><td align="center" rowspan="1" colspan="1">Health&#8208;related habits and behaviours</td><td align="center" rowspan="1" colspan="1">Marburg Questionnaire on Habitual Health (MQHH) [<xref rid="jep70029-bib-0043" ref-type="bibr">43</xref>]</td><td align="center" rowspan="1" colspan="1">1 (4.3)</td></tr></tbody></table><permissions><copyright-holder>John Wiley &amp; Sons, Ltd.</copyright-holder></permissions></table-wrap><table-wrap position="float" id="jep70029-tbl-0005" content-type="Table" orientation="portrait"><label>Table 5</label><caption><p>Patient Experience outcome measure tools identified and their usage frequencies in the included studies (<italic toggle="yes">n</italic>&#8201;=&#8201;23).</p></caption><table frame="hsides" rules="groups"><col style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" align="left" span="1"/><col style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" align="center" span="1"/><col style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" align="center" span="1"/><thead><tr style="border-bottom:solid 1px #000000"><th align="left" rowspan="1" colspan="1">Domains</th><th align="center" rowspan="1" colspan="1">Tools</th><th align="center" rowspan="1" colspan="1">
<italic toggle="yes">N</italic> (%)</th></tr></thead><tbody><tr><td rowspan="10" align="left" colspan="1">Patient perspectives on healthcare: experience, satisfaction, knowledge, and health status change</td><td align="center" rowspan="1" colspan="1">The Barriers Questionnaire II [<xref rid="jep70029-bib-0034" ref-type="bibr">34</xref>, <xref rid="jep70029-bib-0049" ref-type="bibr">49</xref>]</td><td align="center" rowspan="1" colspan="1">2 (8.6)</td></tr><tr><td align="center" rowspan="1" colspan="1">Patient Satisfaction Survey [<xref rid="jep70029-bib-0045" ref-type="bibr">45</xref>]</td><td align="center" rowspan="1" colspan="1">1 (4.3)</td></tr><tr><td align="center" rowspan="1" colspan="1">Satisfaction ratings scale [<xref rid="jep70029-bib-0035" ref-type="bibr">35</xref>]</td><td align="center" rowspan="1" colspan="1">1 (4.3)</td></tr><tr><td align="center" rowspan="1" colspan="1">Treatment Satisfaction for Medication Questionnaire (SATMED&#8208;Q) [<xref rid="jep70029-bib-0051" ref-type="bibr">51</xref>]</td><td align="center" rowspan="1" colspan="1">1 (4.3)</td></tr><tr><td align="center" rowspan="1" colspan="1">American Pain Society Patient Outcome [<xref rid="jep70029-bib-0039" ref-type="bibr">39</xref>]</td><td align="center" rowspan="1" colspan="1">1 (4.3)</td></tr><tr><td align="center" rowspan="1" colspan="1">Patient satisfaction with pain management [<xref rid="jep70029-bib-0034" ref-type="bibr">34</xref>]</td><td align="center" rowspan="1" colspan="1">1 (4.3)</td></tr><tr><td align="center" rowspan="1" colspan="1">Pre&#8208; and post&#8208;knowledge assessment question [<xref rid="jep70029-bib-0045" ref-type="bibr">45</xref>]</td><td align="center" rowspan="1" colspan="1">1 (4.3)</td></tr><tr><td align="center" rowspan="1" colspan="1">The Pain Treatment Satisfaction Scale (PTSS) [<xref rid="jep70029-bib-0049" ref-type="bibr">49</xref>]</td><td align="center" rowspan="1" colspan="1">1 (4.3)</td></tr><tr><td align="center" rowspan="1" colspan="1">The Patient Global Impression of Change (PGIC) [<xref rid="jep70029-bib-0040" ref-type="bibr">40</xref>]</td><td align="center" rowspan="1" colspan="1">1 (4.3)</td></tr><tr><td align="center" rowspan="1" colspan="1">5&#8208;point Likert scale [<xref rid="jep70029-bib-0031" ref-type="bibr">31</xref>]</td><td align="center" rowspan="1" colspan="1">1 (4.3)</td></tr></tbody></table><permissions><copyright-holder>John Wiley &amp; Sons, Ltd.</copyright-holder></permissions></table-wrap><table-wrap position="float" id="jep70029-tbl-0006" content-type="Table" orientation="portrait"><label>Table 6</label><caption><p>Medication related adverse event outcome measure tools identified and their usage frequencies in the included studies (<italic toggle="yes">n</italic>&#8201;=&#8201;23).</p></caption><table frame="hsides" rules="groups"><col style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" align="left" span="1"/><col style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" align="center" span="1"/><col style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" align="center" span="1"/><thead><tr style="border-bottom:solid 1px #000000"><th align="left" rowspan="1" colspan="1">Domains</th><th align="center" rowspan="1" colspan="1">Tools</th><th align="center" rowspan="1" colspan="1">
<italic toggle="yes">N</italic> (%)</th></tr></thead><tbody><tr><td rowspan="2" align="left" colspan="1">Patient&#8208;reported side effects and tolerability</td><td align="center" rowspan="1" colspan="1">Patients reporting or by reviewing the history of drug&#8208;related adverse events in medical records [<xref rid="jep70029-bib-0030" ref-type="bibr">30</xref>, <xref rid="jep70029-bib-0033" ref-type="bibr">33</xref>, <xref rid="jep70029-bib-0035" ref-type="bibr">35</xref>, <xref rid="jep70029-bib-0040" ref-type="bibr">40</xref>]</td><td align="center" rowspan="1" colspan="1">4 (17.3)</td></tr><tr><td align="center" rowspan="1" colspan="1">Patient self&#8208;administered questionnaire [<xref rid="jep70029-bib-0049" ref-type="bibr">49</xref>]</td><td align="center" rowspan="1" colspan="1">1 (4.3)</td></tr><tr><td align="left" rowspan="1" colspan="1">Risk assessment for adverse events</td><td align="center" rowspan="1" colspan="1">Screener and Opioid Assessment for Patients with Pain (SOAPP&#8208;R) risk assessment tool [<xref rid="jep70029-bib-0042" ref-type="bibr">42</xref>]</td><td align="center" rowspan="1" colspan="1">1 (4.3)</td></tr></tbody></table><permissions><copyright-holder>John Wiley &amp; Sons, Ltd.</copyright-holder></permissions></table-wrap><table-wrap position="float" id="jep70029-tbl-0007" content-type="Table" orientation="portrait"><label>Table 7</label><caption><p>Medication Optimisation outcome measure tools identified and their usage frequencies in the included studies (<italic toggle="yes">n</italic>&#8201;=&#8201;23).</p></caption><table frame="hsides" rules="groups"><col style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" align="left" span="1"/><col style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" align="center" span="1"/><col style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" align="center" span="1"/><thead><tr style="border-bottom:solid 1px #000000"><th align="left" rowspan="1" colspan="1">Domains</th><th align="center" rowspan="1" colspan="1">Tools</th><th align="center" rowspan="1" colspan="1">
<italic toggle="yes">N</italic> (%)</th></tr></thead><tbody><tr><td rowspan="2" align="left" colspan="1">Changes in concurrent pain medications</td><td align="center" rowspan="1" colspan="1">Patient chart review or medication records retrieved from electronic system [<xref rid="jep70029-bib-0045" ref-type="bibr">45</xref>, <xref rid="jep70029-bib-0046" ref-type="bibr">46</xref>]</td><td align="center" rowspan="1" colspan="1">2 (8.6)</td></tr><tr><td align="center" rowspan="1" colspan="1">Changes in pain medication survey [<xref rid="jep70029-bib-0036" ref-type="bibr">36</xref>]</td><td align="center" rowspan="1" colspan="1">1 (4.3)</td></tr></tbody></table><permissions><copyright-holder>John Wiley &amp; Sons, Ltd.</copyright-holder></permissions></table-wrap><table-wrap position="float" id="jep70029-tbl-0008" content-type="Table" orientation="portrait"><label>Table 8</label><caption><p>Cost effectiveness outcome measure tools identified and their usage frequencies in the included studies (<italic toggle="yes">n</italic>&#8201;=&#8201;23).</p></caption><table frame="hsides" rules="groups"><col style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" align="left" span="1"/><col style="border-right:solid 1px #000000; border-bottom:solid 1px #000000" align="center" span="1"/><thead><tr style="border-bottom:solid 1px #000000"><th align="left" rowspan="1" colspan="1">Tools</th><th align="center" rowspan="1" colspan="1">
<italic toggle="yes">N</italic> (%)</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Incremental cost&#8208;utility ratio (ICUR) and incremental cost&#8208;effectiveness ratio (ICER) [<xref rid="jep70029-bib-0032" ref-type="bibr">32</xref>]<p>
<list list-type="simple"><list-item><label>&#8211;</label><p>Decision tree and Markov model used for analysis.</p></list-item><list-item><label>&#8211;</label><p>ICUR was calculated per QALY gained, utilising EQ&#8208;5D&#8208;5L health questionnaires.</p></list-item><list-item><label>&#8211;</label><p>ICER was calculated per Numeric Rating Pain Score (NRS) reduction.</p></list-item><list-item><label>&#8211;</label><p>Resource consumption collected from a societal perspective.</p></list-item></list>
</p>
</td><td align="center" rowspan="1" colspan="1">1 (4.3)</td></tr><tr><td align="left" rowspan="1" colspan="1">Incremental cost&#8208;effectiveness ratio (ICER) [<xref rid="jep70029-bib-0041" ref-type="bibr">41</xref>]<p>
<list list-type="simple"><list-item><label>&#8211;</label><p>QALYs calculated from SF&#8208;12 Health Survey assessments</p></list-item><list-item><label>&#8211;</label><p>Resource consumption assessed from a societal perspective.</p></list-item></list>
</p>
</td><td align="center" rowspan="1" colspan="1">1 (4.3)</td></tr><tr><td align="left" rowspan="1" colspan="1">Incremental cost&#8208;effectiveness ratio (ICER) [<xref rid="jep70029-bib-0047" ref-type="bibr">47</xref>]<p>
<list list-type="simple"><list-item><label>&#8211;</label><p>12&#8208;month Markov model used from payer and societal perspectives.</p></list-item><list-item><label>&#8211;</label><p>Measured QALYs from EQ&#8208;5D&#8208;5L questionnaire and Numerical Rating Scale (NRS) for pain severity.</p></list-item><list-item><label>&#8211;</label><p>Direct medical costs estimated based on a physician survey.</p></list-item></list>
</p>
</td><td align="center" rowspan="1" colspan="1">1 (4.3)</td></tr></tbody></table><permissions><copyright-holder>John Wiley &amp; Sons, Ltd.</copyright-holder></permissions></table-wrap><fig position="float" fig-type="Figure" id="jep70029-fig-0002" orientation="portrait"><label>Figure 2.</label><caption><p>The most used outcome measures across all domains (<italic toggle="yes">n =</italic> 23) ADR, Adverse Drug Reaction; BPI, The Brief Pain Inventory; EQ&#8208;5D&#8208;5L, The EuroQol 5 Dimension 5 Level; HADS, Hospital Anxiety and Depression Scale; ICER, Incremental cost&#8208;effectiveness ratio; NPRS, Numerical Pain Rating Scale; NRS, Numerical Rating Scale; QALYs, Quality&#8208;Adjusted Life Years; RMDQ, Roland&#8208;Morris Disability Questionnaire; SDI, Sheehan Disability Inventory.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" id="jats-graphic-3" orientation="portrait" xlink:href="JEP-31-0-g002.jpg"/></fig></sec><sec id="jep70029-sec-0160"><label>3.3</label><title>HRQoL</title><p>A total of 33 tools were identified to assess various domains of Health&#8208;Related Quality of Life (HRQoL) across 23 studies, contributing to 64.7% of the total tools (51 tools) identified (Table&#160;<xref rid="jep70029-tbl-0004" ref-type="table">4</xref>).</p><sec id="jep70029-sec-0170"><label>3.3.1</label><title>Physical Health</title><p>Studies assessed the impact on physical health by measuring pain intensity and its effect on sleep (Table&#160;<xref rid="jep70029-tbl-0004" ref-type="table">4</xref>). Five different tools were used to assess pain intensity in 13 studies (<italic toggle="yes">n</italic>&#8201;=&#8201;13/23; 56.5%), with the Numeric Pain Rating Scale (NPRS) being the most widely used measure employed in studies (<italic toggle="yes">n</italic>&#8201;=&#8201;7/23; 30.4%). The validation of this tool was confirmed in only two studies, and most of the studied conditions were related to musculoskeletal pain (<italic toggle="yes">n</italic>&#8201;=&#8201;19/23; 82.6%). The Short&#8208;Form McGill Pain Questionnaire (SF&#8208;MPQ) was the second most used, employed in two studies (<italic toggle="yes">n</italic>&#8201;=&#8201;2/23; 8.6%). Additionally, two specific pain assessment tools for neuropathic pain were used: the Neuropathic 4 Pain Questions (DN4) tool and the Pain Detect questionnaire. Both tools administered the questionnaires at baseline and at 3 months or beyond after providing the intervention.</p><p>The impact on sleep was assessed in four studies (<italic toggle="yes">n</italic>&#8201;=&#8201;4/23; 17.3%) using three different tools: the Pain&#8208;Related Sleep&#8208;Interference Scale (PRSIS); the Medical Outcomes Study Sleep Scale (MOS&#8208;Sleep); and the Chronic Pain Sleep Inventory.</p></sec><sec id="jep70029-sec-0180"><label>3.3.2</label><title>Psychological Health</title><p>In terms of assessing the cognitive and emotional response to pain, 7 tools were used in 13 studies (<italic toggle="yes">n</italic>&#8201;=&#8201;13/23; 56.5%) (Table&#160;<xref rid="jep70029-tbl-0004" ref-type="table">4</xref>). The Hospital Anxiety and Depression Scale (HADS) was the most used tool, utilised in five studies (<italic toggle="yes">n</italic>&#8201;=&#8201;5/23; 21.7%). Notably, opioid use was among the most used treatments in those studies.</p><p>The second most common tools were the Beck Depression Inventory (BDI) and the Pain Catastrophising Scale (PCS), both of which were utilised in two studies each (<italic toggle="yes">n</italic>&#8201;=&#8201;2/23; 8.6%). Other tools assessing different psychological aspects like fear of movement, mental health, and pain acceptance are summarised in Table&#160;<xref rid="jep70029-tbl-0004" ref-type="table">4</xref>.</p></sec><sec id="jep70029-sec-0190"><label>3.3.3</label><title>Level of Independence</title><p>In terms of assessing performance status and disability, 8 different tools were utilised in 10 studies (<italic toggle="yes">n</italic>&#8201;=&#8201;10/23; 43.4%). Notably, specific types of pain, such as neck pain, were assessed using the Neck Disability Index (NDI), while back pain was assessed using the Roland&#8208;Morris Disability Questionnaire (RMDQ) and Oswestry Disability Index Survey.</p></sec><sec id="jep70029-sec-0200"><label>3.3.4</label><title>Social Relationships</title><p>In assessing the impact of the intervention on social life and responsibility, only one study utilised the Sheehan Disability Inventory (SDI) tool, which was used in refractory chronic neuropathic pain patients treated with pregabalin.</p></sec><sec id="jep70029-sec-0210"><label>3.3.5</label><title>Tools Assessing Multiple Domains of HRQoL</title><p>Nine multidimensional tools were commonly used to assess multiple domains across all included studies (<italic toggle="yes">n</italic>&#8201;=&#8201;23/23; 100%) (Table&#160;<xref rid="jep70029-tbl-0004" ref-type="table">4</xref>). The Brief Pain Inventory (BPI) was the most frequently used tool (<italic toggle="yes">n</italic>&#8201;=&#8201;9/23; 39.1%) to assess pain intensity and its impact on daily activities. Additionally, the European Quality of Life&#8208;5 Dimensions (EQ&#8208;5D) was employed in 5 studies (<italic toggle="yes">n</italic>&#8201;=&#8201;5; 21.7%) to assess mobility, self&#8208;care, usual activities, pain/discomfort, and anxiety/depression.</p><p>The American Pain Society Patient Outcome Questionnaire was included in both the patient experience domain and the multidimensional HRQoL tools (Table&#160;<xref rid="jep70029-tbl-0004" ref-type="table">4</xref>). The questionnaire assesses pain intensity, physical function, emotional well&#8208;being, and patient experience, making it a valuable tool for capturing multiple aspects.</p></sec></sec><sec id="jep70029-sec-0220"><label>3.4</label><title>Patient Experience</title><p>Patient experience, including perspectives on healthcare, satisfaction, knowledge, and health status change, was assessed in 11 studies (<italic toggle="yes">n</italic>&#8201;=&#8201;11/23; 47.8%) using 10 different tools (Table&#160;<xref rid="jep70029-tbl-0005" ref-type="table">5</xref>). It was noted that in some studies, researchers used multiple tools to assess patient experience. For instance, the Patient Satisfaction with Pain Management questionnaire was used together with the Barriers Questionnaire II [<xref rid="jep70029-bib-0034" ref-type="bibr">34</xref>], and similarly, the Patient Satisfaction Survey was used alongside the Pre&#8208; and Post&#8208;Knowledge Assessment Questionnaire [<xref rid="jep70029-bib-0045" ref-type="bibr">45</xref>].</p></sec><sec id="jep70029-sec-0230"><label>3.5</label><title>Medication&#8208;Related Adverse Events</title><p>In total, 6 studies (<italic toggle="yes">n</italic>&#8201;=&#8201;6/23; 26%) were dedicated to assessing adverse events (Table&#160;<xref rid="jep70029-tbl-0006" ref-type="table">6</xref>). Among them, four studies (<italic toggle="yes">n</italic>&#8201;=&#8201;4/23; 17.3%) relied on patient&#8208;reported adverse events or reviewed drug&#8208;related adverse events in medical records. One study used a specific patient self&#8208;administered questionnaire to assess side effects [<xref rid="jep70029-bib-0049" ref-type="bibr">49</xref>], while another study utilised the Screener and Opioid Assessment for Patients with Pain (SOAPP&#8208;R) risk assessment tool to evaluate the risk of adverse events [<xref rid="jep70029-bib-0042" ref-type="bibr">42</xref>].</p></sec><sec id="jep70029-sec-0240"><label>3.6</label><title>Medication Optimisation</title><p>Only three studies (<italic toggle="yes">n</italic>&#8201;=&#8201;3/23; 13%) assessed changes in concurrent pain medications and medication optimisation using three tools (Table&#160;<xref rid="jep70029-tbl-0007" ref-type="table">7</xref>). The most used approach (<italic toggle="yes">n</italic>&#8201;=&#8201;2/23; 8.6%) was patient chart review or medication records retrieved from electronic systems, where pharmacists were responsible for recording medication usage. Additionally, one study used a survey to assess changes in pain medication use [<xref rid="jep70029-bib-0042" ref-type="bibr">42</xref>].</p></sec><sec id="jep70029-sec-0250"><label>3.7</label><title>Cost&#8208;Effectiveness</title><p>Three studies were conducted to assess cost&#8208;effectiveness (<italic toggle="yes">n</italic>&#8201;=&#8201;3/23; 13%) (Table&#160;<xref rid="jep70029-tbl-0008" ref-type="table">8</xref>). In the first study, cost&#8208;effectiveness was evaluated using the Incremental Cost&#8208;Utility Ratio (ICUR) per Quality&#8208;Adjusted Life Year (QALY) gained, based on EQ&#8208;5D&#8208;5L health questionnaires, and the Incremental Cost&#8208;Effectiveness Ratio (ICER) per Numeric Rating Pain Score (NRS) reduction. These calculations were performed using a decision tree and Markov model, with resource consumption data collected from a societal perspective [<xref rid="jep70029-bib-0032" ref-type="bibr">32</xref>].</p><p>In the second study, the ICER was used to evaluate cost&#8208;effectiveness, with Quality&#8208;Adjusted Life Years (QALYs) calculated from Short Form&#8208;12 Health Survey (SF&#8208;12) assessments. Resource consumption was assessed from a societal perspective, considering direct medical and nonmedical costs in various categories [<xref rid="jep70029-bib-0041" ref-type="bibr">41</xref>].</p><p>In the third study, the ICER was employed to assess cost&#8208;effectiveness through a cohort simulation based on a 12&#8208;month Markov model from both payer and societal perspectives. The effectiveness measures included QALYs derived from the EQ&#8208;5D&#8208;5L questionnaire and the Numerical Rating Scale (NRS) for pain severity, with direct medical costs for pain severity levels estimated from a physician survey [<xref rid="jep70029-bib-0047" ref-type="bibr">47</xref>].</p></sec></sec><sec sec-type="discussion" id="jep70029-sec-0260"><label>4</label><title>Discussion</title><p>The aim of this systematic review was to identify and evaluate outcome measures applied in primary care&#8208;based pharmacotherapy pain management services provided by healthcare professionals, and the tools used to assess these outcomes. Although the findings are intended to be applied specifically in the Scottish context, the findings could aid in the evaluation of various primary care designs of pain management and support research and practice globally.</p><p>In this systematic review, 51 tools were identified to assess outcomes in chronic pain across the 23 included studies. Most studies examined only one to two outcomes (out of the five predefined outcomes). Health&#8208;Related Quality of Life (HRQoL) was the most frequently assessed outcome, using the commonly employed tool, the Brief Pain Inventory (BPI), to evaluate both pain intensity and its impact on daily activities. On the other hand, medication optimisation and cost&#8208;effectiveness were the least assessed outcomes. Furthermore, the tools used were inadequately described in 60.8% (<italic toggle="yes">n</italic>&#8201;=&#8201;14/23) of the studies, and there was considerable variability in the timing and frequency of applying the measurement tools among studies (Supporting Information&#160;<xref rid="jep70029-suppl-0004" ref-type="supplementary-material">S4</xref>). Additionally, limited details were provided regarding the validation of the tools before their utilisation.</p><p>The results of this review demonstrated that assessing the HRQoL physical health outcome through pain intensity using the Numeric Pain Rating Scale (NPRS) tool was the most frequently evaluated domain and tool, which was consistent with several other reviews that investigated outcome measures in chronic pain [<xref rid="jep70029-bib-0006" ref-type="bibr">6</xref>, <xref rid="jep70029-bib-0007" ref-type="bibr">7</xref>, <xref rid="jep70029-bib-0008" ref-type="bibr">8</xref>, <xref rid="jep70029-bib-0053" ref-type="bibr">53</xref>]. This finding aligned with the International Neuropathic Pain Special Interest Group (NeuPSIG) guidelines, which recommended the use of NPRS for evaluating pain intensity and treatment effectiveness [<xref rid="jep70029-bib-0054" ref-type="bibr">54</xref>].</p><p>In this review, it was found that most studies examined only one to two of the predefined outcomes. This aligns with findings from other systematic reviews assessing chronic musculoskeletal pain [<xref rid="jep70029-bib-0007" ref-type="bibr">7</xref>] and neuropathic pain [<xref rid="jep70029-bib-0053" ref-type="bibr">53</xref>]. This could possibly be driven by the complexity and multifaceted nature of chronic pain, which might make it challenging to comprehensively capture all relevant outcomes within a single study, and the need to minimise patient assessment burden, time constraints, and ease of administration [<xref rid="jep70029-bib-0007" ref-type="bibr">7</xref>]. This observation is supported by several studies investigating the utility and responsiveness of various pain measures, which reported that short and simple assessment tools were more responsive than more complex tools [<xref rid="jep70029-bib-0055" ref-type="bibr">55</xref>, <xref rid="jep70029-bib-0056" ref-type="bibr">56</xref>]. However, a notable distinction in our review was that each of the included studies utilised at least one multidimensional tool (100%), covering multiple domains. In contrast, Litcher&#8208;Kelly et al. and Dosenovic et al. employed multidimensional tools in less than 16% of the included studies, focusing on a single&#8208;dimension target tool [<xref rid="jep70029-bib-0007" ref-type="bibr">7</xref>, <xref rid="jep70029-bib-0053" ref-type="bibr">53</xref>]. This variation could be attributed to the type of included studies, which were controlled trials aiming primarily to assess changes in pain intensity and were confined to specific types of chronic pain (e.g., neuropathic, musculoskeletal pain), potentially limiting the range of applicable measures to those conditions. In contrast, this review included observational studies that capture a more real&#8208;world evaluation, covering all types of chronic pain.</p><p>In this systematic review, 60.8% (<italic toggle="yes">n</italic>&#8201;=&#8201;14) of the included studies lacked detail when describing the tools used (e.g., frequency of use, reasons for selection) and did not provide insights into the validation of the tools used (Table&#160;<xref rid="jep70029-suppl-0005" ref-type="supplementary-material">S5</xref>). This finding was consistent with other reviews assessing chronic pain outcome measures [<xref rid="jep70029-bib-0007" ref-type="bibr">7</xref>, <xref rid="jep70029-bib-0008" ref-type="bibr">8</xref>]. By utilising validated measures, healthcare professionals can gain a better insight into the outcomes, enhancing the credibility and reliability of the study findings [<xref rid="jep70029-bib-0035" ref-type="bibr">35</xref>].</p><p>Cost&#8208;effectiveness was one of the two least assessed outcomes in this review (13%), which was even lower (6%) in another systematic review conducted by Dosenovic et al. assessing outcome measures in neuropathic pain [<xref rid="jep70029-bib-0053" ref-type="bibr">53</xref>]. Limited inclusion of cost&#8208;effectiveness can be attributed to factors such as the need for substantial financial resources and specialised expertise, prioritisation of clinical outcomes and patient experiences, complexity, time&#8208;consuming nature of the analysis, and challenges with data availability on healthcare resource utilisation and costs [<xref rid="jep70029-bib-0057" ref-type="bibr">57</xref>].</p><sec id="jep70029-sec-0270"><label>4.1</label><title>Study Strengths and Limitations</title><p>In this systematic review, we acknowledge both strengths and limitations. The comprehensive search strategy accurately identified a wide range of chronic pain diseases using MeSH terms and keywords across different databases, along with hand searches to minimise the risk of missing relevant studies. We included all types of chronic pain and measures, assessed by healthcare providers or patients, as well as various timeframes for conducting interventions. Furthermore, this review underwent rigorous validation by two authors, including a quality assessment of all included studies, with a risk of bias assessment forming a key characteristic of a systematic review methodology. The quality of the identified studies was high (13 of the 15 cohort studies and 7 of the 8 cross&#8208;sectional studies scored as high quality), showing that the outcomes extracted came from high&#8208;quality studies.</p><p>The consensus outcome framework of pharmacotherapy services in Scotland was adopted as the basis for assessing outcomes in this review [<xref rid="jep70029-bib-0009" ref-type="bibr">9</xref>], however there are other reviews [<xref rid="jep70029-bib-0006" ref-type="bibr">6</xref>, <xref rid="jep70029-bib-0053" ref-type="bibr">53</xref>] assessing chronic pain which use the Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials (IMMPACT) framework [<xref rid="jep70029-bib-0058" ref-type="bibr">58</xref>]. The IMMPACT framework was not considered in this study due to its primary focus on clinical trials, whereas this review concentrated on observational studies. Furthermore, the Scottish consensus framework covered all the outcome areas within the IMMPACT framework with addition of medication optimisation and cost&#8208;effectiveness domains. Moreover, the five&#8208;predefined outcomes adopted in this systematic review was developed by pharmacists experienced in delivering pharmacotherapy services in varied clinical conditions beyond but including chronic pain management providing the potential for applicability of these findings to other clinical service areas. We acknowledge that the inclusion of clinical trials could have provided further insights, especially regarding cost&#8208;effectiveness outcomes, but it may have limited the overall assessment scope to treatment&#8208;related targets (e.g., pain intensity). However, this review aimed to identify tools being used in routine clinical practice hence the focus on assessment of observational studies with the goal to inform potential tools to adopt as part of a pharmacotherapy service in primary care. Moreover, we recognise that although cohort studies provide an insight into clinical practice, their nature as research studies may not necessarily provide an accurate reflection of everyday clinical practice. Finally, limited descriptions of assessment tools in some articles posed challenges in identifying the main domain target, but these challenges were addressed by conducting additional literature searches for clarification.</p></sec><sec id="jep70029-sec-0280"><label>4.2</label><title>Future Research and Implications</title><p>This research can be beneficial for researchers and healthcare providers by providing a comprehensive list of available tools used in observational studies classified according to domain coverage. It aids in choosing the most suitable tool for specific study settings. To further advance this field, validation of the identified tools should be conducted rigorously to ensure greater consistency and standardised assessments of chronic pain services. The findings of this work intend to be integrated within the Scottish primary care system to evaluate the outcomes of pharmacy&#8208;led pain clinics, which is of importance considering the novelty of the delivery model. However, the findings can be applied throughout any primary care setting globally to inform evidence&#8208;based evaluations of pain management and support and may provide useful cross&#8208;comparison between different delivery models. Furthermore, future research could incorporate nonpharmacological alongside pharmacological to provide a more comprehensive perspective on chronic pain management in outpatient settings.</p><p>The International Consortium for Health Outcomes Measurement (ICHOM) focuses on defining global patient&#8208;centred outcome measures in various disease conditions, and creating standard outcome sets for clinical conditions and certain populations [<xref rid="jep70029-bib-0059" ref-type="bibr">59</xref>]. However, general chronic pain measures have not yet been included in their scope, and this study could provide a starting point for identifying the best outcome measures for use in chronic pain.</p></sec></sec><sec sec-type="conclusions" id="jep70029-sec-0290"><label>5</label><title>Conclusions</title><p>This review highlights gaps in enabling a more holistic assessment of pharmacotherapy services, given the diversity of outcome measures being utilised. It underscores the need for enhanced consistency by validating the identified tools and adopting standardised tools in clinical practice. Implementing such tools can significantly improve the quality of pharmacotherapy service assessments and, ultimately, contribute to more effective patient care and improved healthcare outcomes.</p></sec><sec id="jep70029-sec-0300"><title>Author Contributions</title><p>Marion Bennie, Rosemary Newham and Natalie Weir were responsible for the overall research programme conceptualisation for this work. Marion Bennie, Emma Dunlop and Natalie Weir developed the study aim. Abdulrahman Sharaf with Marion Bennie, Emma Dunlop and Natalie Weir developed the study methodology and search strategy. Abdulrahman Sharaf conducted the literature search and analysed the data. Sumaya Alsalah, Natalie Weir and Emma Dunlop performed validation of the work. Abdulrahman Sharaf wrote the draft manuscript, with contribution from Emma Dunlop, Natalie Weir, Rosemary Newham and Marion Bennie.</p></sec><sec sec-type="COI-statement" id="jep70029-sec-0320"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest.</p></sec><sec sec-type="supplementary-material"><title>Supporting information</title><supplementary-material id="jep70029-suppl-0001" position="float" content-type="local-data" orientation="portrait"><caption><p>Supporting information.</p></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="JEP-31-0-s001.docx" position="float" orientation="portrait"/></supplementary-material><supplementary-material id="jep70029-suppl-0002" position="float" content-type="local-data" orientation="portrait"><caption><p>Supporting information.</p></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="JEP-31-0-s003.docx" position="float" orientation="portrait"/></supplementary-material><supplementary-material id="jep70029-suppl-0003" position="float" content-type="local-data" orientation="portrait"><caption><p>Supporting information.</p></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="JEP-31-0-s002.docx" position="float" orientation="portrait"/></supplementary-material><supplementary-material id="jep70029-suppl-0004" position="float" content-type="local-data" orientation="portrait"><caption><p>Supporting information.</p></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="JEP-31-0-s005.docx" position="float" orientation="portrait"/></supplementary-material><supplementary-material id="jep70029-suppl-0005" position="float" content-type="local-data" orientation="portrait"><caption><p>Supporting information.</p></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="JEP-31-0-s004.docx" position="float" orientation="portrait"/></supplementary-material></sec></body><back><ack id="jep70029-sec-0310"><title>Acknowledgements</title><p>Thanks to Dr Aimee Ferguson for her assistance in the manuscript preparation. Thanks to the Scottish Practice Pharmacy &amp; Prescribing Advisers Group and Scottish Pain Pharmacy Network for their support for and oversight of this work.</p></ack><sec sec-type="data-availability" id="jep70029-sec-0340"><title>Data Availability Statement</title><p>The authors have nothing to report.</p></sec><ref-list id="jep70029-bibl-0001" content-type="cited-references"><title>References</title><ref id="jep70029-bib-0001"><label>1</label><mixed-citation publication-type="journal" id="jep70029-cit-0001"><string-name name-style="western"><given-names>R. D.</given-names><surname>Treede</surname></string-name>, <string-name name-style="western"><given-names>W.</given-names><surname>Rief</surname></string-name>, <string-name name-style="western"><given-names>A.</given-names><surname>Barke</surname></string-name>, et al., &#8220;<article-title>A Classification of Chronic Pain for ICD&#8208;11</article-title>,&#8221; <source>Pain</source><volume>156</volume>, no. <issue>6</issue> (June <year>2015</year>): <fpage>1003</fpage>&#8211;<lpage>1007</lpage>, <pub-id pub-id-type="doi">10.1097/j.pain.0000000000000160</pub-id>.<pub-id pub-id-type="pmid">25844555</pub-id><pub-id pub-id-type="pmcid">PMC4450869</pub-id></mixed-citation></ref><ref id="jep70029-bib-0002"><label>2</label><mixed-citation publication-type="miscellaneous" id="jep70029-cit-0002"><collab collab-type="authors">National Institute for Health &amp; Care Excellence (NICE)</collab>
, &#8220;<article-title>Chronic Pain (Primary and Secondary) in Over 16s: Assessment of All Chronic Pain and Management of Chronic Primary Pain (NG193)</article-title>,&#8221; 2021, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.nice.org.uk/guidance/ng193" ext-link-type="uri">https://www.nice.org.uk/guidance/ng193</ext-link>.<pub-id pub-id-type="pmid">33939353</pub-id></mixed-citation></ref><ref id="jep70029-bib-0003"><label>3</label><mixed-citation publication-type="miscellaneous" id="jep70029-cit-0003"><string-name name-style="western"><given-names>C. M.</given-names><surname>Hales</surname></string-name>, <string-name name-style="western"><given-names>C. B.</given-names><surname>Martin</surname></string-name>, and <string-name name-style="western"><given-names>Q.</given-names><surname>Gu</surname></string-name>, <article-title>
<italic toggle="yes">Prevalence of Prescription Pain Medication Use Among Adults: United States, 2015&#8208;2018</italic>. Centers for Disease Control and Prevention</article-title>, <year>2020</year>, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.cdc.gov/nchs/products/databriefs/db369.htm" ext-link-type="uri">https://www.cdc.gov/nchs/products/databriefs/db369.htm</ext-link>.<pub-id pub-id-type="pmid">32600518</pub-id></mixed-citation></ref><ref id="jep70029-bib-0004"><label>4</label><mixed-citation publication-type="journal" id="jep70029-cit-0004"><string-name name-style="western"><given-names>N.</given-names><surname>Hylands&#8208;White</surname></string-name>, <string-name name-style="western"><given-names>R. V.</given-names><surname>Duarte</surname></string-name>, and <string-name name-style="western"><given-names>J. H.</given-names><surname>Raphael</surname></string-name>, &#8220;<article-title>An Overview of Treatment Approaches for Chronic Pain Management</article-title>,&#8221; <source>Rheumatology International</source><volume>37</volume>, no. <issue>1</issue> (<year>2017</year>): <fpage>29</fpage>&#8211;<lpage>42</lpage>, <pub-id pub-id-type="doi">10.1007/s00296-016-3481-8</pub-id>.<pub-id pub-id-type="pmid">27107994</pub-id></mixed-citation></ref><ref id="jep70029-bib-0005"><label>5</label><mixed-citation publication-type="journal" id="jep70029-cit-0005"><string-name name-style="western"><given-names>L. A.</given-names><surname>Uebelacker</surname></string-name>, <string-name name-style="western"><given-names>E. M.</given-names><surname>Cherenack</surname></string-name>, <string-name name-style="western"><given-names>A.</given-names><surname>Busch</surname></string-name>, et al., &#8220;<article-title>Pharmacologic and Non&#8208;Pharmacologic Treatments for Chronic Pain Used by Patients With Pain, HIV, and Depression</article-title>,&#8221; <source>AIDS and Behavior</source><volume>26</volume>, no. <issue>3</issue> (<year>2022</year>): <fpage>864</fpage>&#8211;<lpage>873</lpage>, <pub-id pub-id-type="doi">10.1007/s10461-021-03447-x</pub-id>.<pub-id pub-id-type="pmid">34468967</pub-id><pub-id pub-id-type="pmcid">PMC9125741</pub-id></mixed-citation></ref><ref id="jep70029-bib-0006"><label>6</label><mixed-citation publication-type="journal" id="jep70029-cit-0006"><string-name name-style="western"><given-names>J.</given-names><surname>Sachau</surname></string-name>, <string-name name-style="western"><given-names>M.</given-names><surname>Sendel</surname></string-name>, <string-name name-style="western"><given-names>M.</given-names><surname>P&#233;chard</surname></string-name>, et al., &#8220;<article-title>Patient Reported Outcome Measures in Chronic Neuropathic Pain Clinical Trials &#8208; A Systematic Literature Review</article-title>,&#8221; <source>Journal of Pain</source><volume>24</volume>, no. <issue>1</issue> (<year>2023</year>): <fpage>38</fpage>&#8211;<lpage>54</lpage>, <pub-id pub-id-type="doi">10.1016/j.jpain.2022.09.003</pub-id>.<pub-id pub-id-type="pmid">36216128</pub-id></mixed-citation></ref><ref id="jep70029-bib-0007"><label>7</label><mixed-citation publication-type="journal" id="jep70029-cit-0007"><string-name name-style="western"><given-names>L.</given-names><surname>Litcher&#8208;Kelly</surname></string-name>, <string-name name-style="western"><given-names>S. A.</given-names><surname>Martino</surname></string-name>, <string-name name-style="western"><given-names>J. E.</given-names><surname>Broderick</surname></string-name>, and <string-name name-style="western"><given-names>A. A.</given-names><surname>Stone</surname></string-name>, &#8220;<article-title>A Systematic Review of Measures Used to Assess Chronic Musculoskeletal Pain in Clinical and Randomized Controlled Clinical Trials</article-title>,&#8221; <source>Journal of Pain</source><volume>8</volume>, no. <issue>12</issue> (<year>2007</year>): <fpage>906</fpage>&#8211;<lpage>913</lpage>, <pub-id pub-id-type="doi">10.1016/j.jpain.2007.06.009</pub-id>.<pub-id pub-id-type="pmid">17690014</pub-id><pub-id pub-id-type="pmcid">PMC2691574</pub-id></mixed-citation></ref><ref id="jep70029-bib-0008"><label>8</label><mixed-citation publication-type="journal" id="jep70029-cit-0008"><string-name name-style="western"><given-names>P.</given-names><surname>Mehta</surname></string-name>, <string-name name-style="western"><given-names>L.</given-names><surname>Claydon</surname></string-name>, <string-name name-style="western"><given-names>P.</given-names><surname>Hendrick</surname></string-name>, <string-name name-style="western"><given-names>S.</given-names><surname>Winser</surname></string-name>, and <string-name name-style="western"><given-names>G. D.</given-names><surname>Baxter</surname></string-name>, &#8220;<article-title>Outcome Measures in Randomized&#8208;Controlled Trials of Neuropathic Pain Conditions: A Systematic Review of Systematic Reviews and Recommendations for Practice</article-title>,&#8221; <source>Clinical Journal of Pain</source><volume>31</volume>, no. <issue>2</issue> (<year>2015</year>): <fpage>169</fpage>&#8211;<lpage>176</lpage>, <pub-id pub-id-type="doi">10.1097/ajp.0000000000000088</pub-id>.<pub-id pub-id-type="pmid">24662497</pub-id></mixed-citation></ref><ref id="jep70029-bib-0009"><label>9</label><mixed-citation publication-type="journal" id="jep70029-cit-0009"><string-name name-style="western"><given-names>R.</given-names><surname>Newham</surname></string-name>, <string-name name-style="western"><given-names>N.</given-names><surname>Weir</surname></string-name>, <string-name name-style="western"><given-names>A.</given-names><surname>Ferguson</surname></string-name>, and <string-name name-style="western"><given-names>M.</given-names><surname>Bennie</surname></string-name>, &#8220;<article-title>Identifying the Important Outcomes to Measure for Pharmacy&#8208;Led, Clinical Services Within Primary Care: A Nominal Group Technique Approach</article-title>,&#8221; <source>Research in Social and Administrative Pharmacy</source><volume>19</volume>, no. <issue>3</issue> (<year>2023</year>): <fpage>468</fpage>&#8211;<lpage>476</lpage>, <pub-id pub-id-type="doi">10.1016/j.sapharm.2022.11.003</pub-id>.<pub-id pub-id-type="pmid">36404258</pub-id></mixed-citation></ref><ref id="jep70029-bib-0010"><label>10</label><mixed-citation publication-type="journal" id="jep70029-cit-0010"><string-name name-style="western"><given-names>M.</given-names><surname>de Barra</surname></string-name>, <string-name name-style="western"><given-names>C. L.</given-names><surname>Scott</surname></string-name>, <string-name name-style="western"><given-names>N. W.</given-names><surname>Scott</surname></string-name>, et al., &#8220;<article-title>Pharmacist Services for Non&#8208;Hospitalised Patients</article-title>,&#8221; <source>Cochrane Database of Systematic Reviews</source><volume>9</volume>, no. <issue>9</issue> (<year>2018</year>): <elocation-id>Cd013102</elocation-id>, <pub-id pub-id-type="doi">10.1002/14651858.Cd013102</pub-id>.<pub-id pub-id-type="pmid">30178872</pub-id><pub-id pub-id-type="pmcid">PMC6513292</pub-id></mixed-citation></ref><ref id="jep70029-bib-0011"><label>11</label><mixed-citation publication-type="book" id="jep70029-cit-0011"><string-name name-style="western"><given-names>S.</given-names><surname>Nundy</surname></string-name>, <string-name name-style="western"><given-names>A.</given-names><surname>Kakar</surname></string-name>, and <string-name name-style="western"><given-names>Z. A.</given-names><surname>Bhutta</surname></string-name>, &#8220;<part-title>Systematic, Scoping and Narrative Reviews</part-title>,&#8221; in <source>How to Practice Academic Medicine and Publish From Developing Countries</source> (<publisher-loc>Singapore</publisher-loc>: <publisher-name>Springer</publisher-name>, <year>2022</year>), <pub-id pub-id-type="doi">10.1007/978-981-16-5248-6_29</pub-id>.</mixed-citation></ref><ref id="jep70029-bib-0012"><label>12</label><mixed-citation publication-type="journal" id="jep70029-cit-0012"><string-name name-style="western"><given-names>M. J.</given-names><surname>Page</surname></string-name>, <string-name name-style="western"><given-names>J. E.</given-names><surname>McKenzie</surname></string-name>, <string-name name-style="western"><given-names>P. M.</given-names><surname>Bossuyt</surname></string-name>, et al., &#8220;<article-title>The PRISMA 2020 Statement: An Updated Guideline for Reporting Systematic Reviews</article-title>,&#8221; <source>BMJ</source><volume>372</volume> (<year>2021</year>): <elocation-id>n71</elocation-id>, <pub-id pub-id-type="doi">10.1136/bmj.n71</pub-id>.<pub-id pub-id-type="pmid">33782057</pub-id><pub-id pub-id-type="pmcid">PMC8005924</pub-id></mixed-citation></ref><ref id="jep70029-bib-0013"><label>13</label><mixed-citation publication-type="book" id="jep70029-cit-0013"><string-name name-style="western"><given-names>A. A.</given-names><surname>Anekar</surname></string-name>, <string-name name-style="western"><given-names>J. M.</given-names><surname>Hendrix</surname></string-name>, and <string-name name-style="western"><given-names>M.</given-names><surname>Cascella</surname></string-name>, &#8220;<part-title>WHO Analgesic Ladder</part-title>,&#8221; in <source>StatPearls</source> [Internet]. <publisher-loc>(Treasure Island (FL)</publisher-loc>: <publisher-name>StatPearls Publishing</publisher-name>, <year>2025</year>), <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK554435/" ext-link-type="uri">https://www.ncbi.nlm.nih.gov/books/NBK554435/</ext-link>.<pub-id pub-id-type="pmid">32119322</pub-id></mixed-citation></ref><ref id="jep70029-bib-0014"><label>14</label><mixed-citation publication-type="journal" id="jep70029-cit-0014"><string-name name-style="western"><given-names>B. H.</given-names><surname>Smith</surname></string-name>, <string-name name-style="western"><given-names>J. D.</given-names><surname>Hardman</surname></string-name>, <string-name name-style="western"><given-names>A.</given-names><surname>Stein</surname></string-name>, and <string-name name-style="western"><given-names>L.</given-names><surname>Colvin</surname></string-name>, &#8220;<article-title>Managing Chronic Pain in the Non&#8208;Specialist Setting: A New Sign Guideline</article-title>,&#8221; <source>British Journal of General Practice</source><volume>64</volume>, no. <issue>624</issue> (<year>2014</year>): <fpage>e462</fpage>&#8211;<lpage>e464</lpage>, <pub-id pub-id-type="doi">10.3399/bjgp14X680737</pub-id>.<pub-id pub-id-type="pmcid">PMC4073734</pub-id><pub-id pub-id-type="pmid">24982501</pub-id></mixed-citation></ref><ref id="jep70029-bib-0015"><label>15</label><mixed-citation publication-type="journal" id="jep70029-cit-0015"><string-name name-style="western"><given-names>M.</given-names><surname>Ouzzani</surname></string-name>, <string-name name-style="western"><given-names>H.</given-names><surname>Hammady</surname></string-name>, <string-name name-style="western"><given-names>Z.</given-names><surname>Fedorowicz</surname></string-name>, and <string-name name-style="western"><given-names>A.</given-names><surname>Elmagarmid</surname></string-name>, &#8220;<article-title>Rayyan&#8212;A Web and Mobile App for Systematic Reviews</article-title>,&#8221; <source>Systematic Reviews</source><volume>5</volume>, no. <issue>1</issue> (<year>2016</year>): <fpage>210</fpage>, <pub-id pub-id-type="doi">10.1186/s13643-016-0384-4</pub-id>.<pub-id pub-id-type="pmid">27919275</pub-id><pub-id pub-id-type="pmcid">PMC5139140</pub-id></mixed-citation></ref><ref id="jep70029-bib-0016"><label>16</label><mixed-citation publication-type="journal" id="jep70029-cit-0016"><string-name name-style="western"><given-names>R. N.</given-names><surname>Aileen</surname></string-name>, <string-name name-style="western"><given-names>B.</given-names><surname>Hanne</surname></string-name>, <string-name name-style="western"><given-names>M. B.</given-names><surname>Christine</surname></string-name>, et al., &#8220;<article-title>Pharmacist&#8208;Led Management of Chronic Pain in Primary Care: Costs and Benefits in a Pilot Randomised Controlled Trial</article-title>,&#8221; <source>BMJ Open</source><volume>5</volume>, no. <issue>4</issue> (<year>2015</year>): <elocation-id>e006874</elocation-id>, <pub-id pub-id-type="doi">10.1136/bmjopen-2014-006874</pub-id>.<pub-id pub-id-type="pmcid">PMC4390732</pub-id><pub-id pub-id-type="pmid">25833666</pub-id></mixed-citation></ref><ref id="jep70029-bib-0017"><label>17</label><mixed-citation publication-type="journal" id="jep70029-cit-0017"><string-name name-style="western"><given-names>A. L.</given-names><surname>Friedel</surname></string-name>, <string-name name-style="western"><given-names>S.</given-names><surname>Siegel</surname></string-name>, <string-name name-style="western"><given-names>C. F.</given-names><surname>Kirstein</surname></string-name>, et al., &#8220;<article-title>Measuring Patient Experience and Patient Satisfaction&#8208;How Are We Doing It and Why Does It Matter? A Comparison of European and U.S. American Approaches</article-title>,&#8221; <source>Healthcare (Basel, Switzerland)</source><volume>11</volume>, no. <issue>6</issue> (<year>2023</year>): <elocation-id>797</elocation-id>, <pub-id pub-id-type="doi">10.3390/healthcare11060797</pub-id>.<pub-id pub-id-type="pmid">36981454</pub-id><pub-id pub-id-type="pmcid">PMC10048416</pub-id></mixed-citation></ref><ref id="jep70029-bib-0018"><label>18</label><mixed-citation publication-type="journal" id="jep70029-cit-0018"><string-name name-style="western"><given-names>E.</given-names><surname>Larson</surname></string-name>, <string-name name-style="western"><given-names>J.</given-names><surname>Sharma</surname></string-name>, <string-name name-style="western"><given-names>M. A.</given-names><surname>Bohren</surname></string-name>, and <string-name name-style="western"><given-names>&#214;.</given-names><surname>Tun&#231;alp</surname></string-name>, &#8220;<article-title>When the Patient Is the Expert: Measuring Patient Experience and Satisfaction With Care</article-title>,&#8221; <source>Bulletin of the World Health Organization</source><volume>97</volume>, no. <issue>8</issue> (<year>2019</year>): <fpage>563</fpage>&#8211;<lpage>569</lpage>, <pub-id pub-id-type="doi">10.2471/blt.18.225201</pub-id>.<pub-id pub-id-type="pmid">31384074</pub-id><pub-id pub-id-type="pmcid">PMC6653815</pub-id></mixed-citation></ref><ref id="jep70029-bib-0019"><label>19</label><mixed-citation publication-type="journal" id="jep70029-cit-0019"><string-name name-style="western"><given-names>P. R.</given-names><surname>Obreli&#8208;Neto</surname></string-name>, <string-name name-style="western"><given-names>S.</given-names><surname>Marusic</surname></string-name>, <string-name name-style="western"><given-names>C. M.</given-names><surname>Guidoni</surname></string-name>, et al., &#8220;<article-title>Economic Evaluation of a Pharmaceutical Care Program for Elderly Diabetic and Hypertensive Patients in Primary Health Care: A 36&#8208;Month Randomized Controlled Clinical Trial</article-title>,&#8221; <source>Journal of Managed Care &amp; Specialty Pharmacy</source><volume>21</volume>, no. <issue>1</issue> (<year>2015</year>): <fpage>66</fpage>&#8211;<lpage>75</lpage>, <pub-id pub-id-type="doi">10.18553/jmcp.2015.21.1.66</pub-id>.<pub-id pub-id-type="pmid">25562774</pub-id><pub-id pub-id-type="pmcid">PMC10398185</pub-id></mixed-citation></ref><ref id="jep70029-bib-0020"><label>20</label><mixed-citation publication-type="journal" id="jep70029-cit-0020"><string-name name-style="western"><given-names>M.</given-names><surname>Beattie</surname></string-name>, <string-name name-style="western"><given-names>D. J.</given-names><surname>Murphy</surname></string-name>, <string-name name-style="western"><given-names>I.</given-names><surname>Atherton</surname></string-name>, and <string-name name-style="western"><given-names>W.</given-names><surname>Lauder</surname></string-name>, &#8220;<article-title>Instruments to Measure Patient Experience of Healthcare Quality in Hospitals: A Systematic Review</article-title>,&#8221; <source>Systematic Reviews</source><volume>4</volume> (<year>2015</year>): <fpage>97</fpage>, <pub-id pub-id-type="doi">10.1186/s13643-015-0089-0</pub-id>.<pub-id pub-id-type="pmid">26202326</pub-id><pub-id pub-id-type="pmcid">PMC4511995</pub-id></mixed-citation></ref><ref id="jep70029-bib-0021"><label>21</label><mixed-citation publication-type="journal" id="jep70029-cit-0021"><string-name name-style="western"><given-names>N. M.</given-names><surname>Weir</surname></string-name>, <string-name name-style="western"><given-names>K.</given-names><surname>Preston</surname></string-name>, <string-name name-style="western"><given-names>R.</given-names><surname>Newham</surname></string-name>, and <string-name name-style="western"><given-names>M.</given-names><surname>Bennie</surname></string-name>, &#8220;<article-title>Development of a Primary Care Pharmacy Outcomes Framework: An Umbrella Literature Review</article-title>,&#8221; <source>Research in Social and Administrative Pharmacy</source><volume>18</volume>, no. <issue>5</issue> (<year>2022</year>): <fpage>2757</fpage>&#8211;<lpage>2777</lpage>, <pub-id pub-id-type="doi">10.1016/j.sapharm.2021.07.010</pub-id>.<pub-id pub-id-type="pmid">34353755</pub-id></mixed-citation></ref><ref id="jep70029-bib-0022"><label>22</label><mixed-citation publication-type="journal" id="jep70029-cit-0022"><string-name name-style="western"><given-names>T.</given-names><surname>Benson</surname></string-name> and <string-name name-style="western"><given-names>A.</given-names><surname>Benson</surname></string-name>, &#8220;<article-title>Routine Measurement of Patient Experience</article-title>,&#8221; <source>BMJ Open Quality</source><volume>12</volume>, no. <issue>1</issue> (<year>2023</year>): <elocation-id>e002073</elocation-id>, <pub-id pub-id-type="doi">10.1136/bmjoq-2022-002073</pub-id>.<pub-id pub-id-type="pmcid">PMC9884896</pub-id><pub-id pub-id-type="pmid">36707125</pub-id></mixed-citation></ref><ref id="jep70029-bib-0023"><label>23</label><mixed-citation publication-type="journal" id="jep70029-cit-0023"><string-name name-style="western"><given-names>K.</given-names><surname>Megari</surname></string-name>, &#8220;<article-title>Quality of Life in Chronic Disease Patients</article-title>,&#8221; <source>Health Psychology Research</source><volume>1</volume>, no. <issue>3</issue> (<year>2013</year>): <elocation-id>e27</elocation-id>, <pub-id pub-id-type="doi">10.4081/hpr.2013.e27</pub-id>.<pub-id pub-id-type="pmid">26973912</pub-id><pub-id pub-id-type="pmcid">PMC4768563</pub-id></mixed-citation></ref><ref id="jep70029-bib-0024"><label>24</label><mixed-citation publication-type="journal" id="jep70029-cit-0024"><collab collab-type="authors">World Health Organisation</collab>
, &#8220;<article-title>The World Health Organization Quality of Life Assessment (Whoqol): Position Paper From the World Health Organization</article-title>,&#8221; <source>Social Science &amp; Medicine</source><volume>41</volume>, no. <issue>10</issue> (<year>1995</year>): <fpage>1403</fpage>&#8211;<lpage>1409</lpage>, <pub-id pub-id-type="doi">10.1016/0277-9536(95)00112-k</pub-id>.<pub-id pub-id-type="pmid">8560308</pub-id></mixed-citation></ref><ref id="jep70029-bib-0025"><label>25</label><mixed-citation publication-type="book" id="jep70029-cit-0025"><string-name name-style="western"><given-names>C. L.</given-names><surname>Skelly</surname></string-name>, <string-name name-style="western"><given-names>M.</given-names><surname>Cassagnol</surname></string-name>, and <string-name name-style="western"><given-names>S.</given-names><surname>Munakomi</surname></string-name>, &#8220;<part-title>Adverse Events</part-title>,&#8221; in <source>StatPearls</source> (<publisher-name>StatPearls Publishing Copyright &#169; 2024, StatPearls Publishing LLC</publisher-name>, <year>2024</year>).<pub-id pub-id-type="pmid">32644389</pub-id></mixed-citation></ref><ref id="jep70029-bib-0026"><label>26</label><mixed-citation publication-type="journal" id="jep70029-cit-0026"><string-name name-style="western"><given-names>M. S.</given-names><surname>McFarland</surname></string-name>, <string-name name-style="western"><given-names>S. W.</given-names><surname>Finks</surname></string-name>, <string-name name-style="western"><given-names>L.</given-names><surname>Smith</surname></string-name>, et al., &#8220;<article-title>Medication Optimization: Integration of Comprehensive Medication Management Into Practice</article-title>,&#8221; <source>American Health &amp; Drug Benefits</source><volume>14</volume>, no. <issue>3</issue> (<year>2021</year>): <fpage>111</fpage>&#8211;<lpage>114</lpage>.<pub-id pub-id-type="pmid">35261714</pub-id><pub-id pub-id-type="pmcid">PMC8845520</pub-id></mixed-citation></ref><ref id="jep70029-bib-0027"><label>27</label><mixed-citation publication-type="book" id="jep70029-cit-0027"><string-name name-style="western"><given-names>F.</given-names><surname>Lau</surname></string-name>, &#8220;<article-title>Methods for eHealth Economic Evaluation Studies,&#8221; in <italic toggle="yes">Handbook of eHealth Evaluation: An Evidence&#8208;Based Approach</italic>
</article-title>, ed. <person-group person-group-type="editor"><string-name name-style="western"><given-names>F.</given-names><surname>Lau</surname></string-name></person-group> and <person-group person-group-type="editor"><string-name name-style="western"><given-names>C.</given-names><surname>Kuziemsky</surname></string-name></person-group> (<publisher-loc>Victoria (BC)</publisher-loc>: <publisher-name>University of Victoria</publisher-name>, <year>2017</year>), <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK481590/" ext-link-type="uri">https://www.ncbi.nlm.nih.gov/books/NBK481590/</ext-link>.<pub-id pub-id-type="pmid">29431951</pub-id></mixed-citation></ref><ref id="jep70029-bib-0028"><label>28</label><mixed-citation publication-type="miscellaneous" id="jep70029-cit-0028"><string-name name-style="western"><given-names>R.</given-names><surname>Thomas</surname></string-name> and <string-name name-style="western"><given-names>K.</given-names><surname>Chalkidou</surname></string-name>, &#8220;<article-title>Cost&#8208;Effectiveness Analysis</article-title>,&#8221; 2016, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK436886/" ext-link-type="uri">https://www.ncbi.nlm.nih.gov/books/NBK436886/</ext-link>.</mixed-citation></ref><ref id="jep70029-bib-0029"><label>29</label><mixed-citation publication-type="miscellaneous" id="jep70029-cit-0029"><string-name name-style="western"><given-names>G. A.</given-names><surname>Wells</surname></string-name>, <string-name name-style="western"><given-names>G.</given-names><surname>Shea</surname></string-name>, <string-name name-style="western"><given-names>B.</given-names><surname>Shea</surname></string-name>, et al., &#8220;The Newcastle&#8208;Ottawa Scale (NOS) for Assessing the Quality of Nonrandomised Studies in Meta&#8208;Analyses,&#8221; <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.ohri.ca/programs/clinical_epidemiology/oxford.asp" ext-link-type="uri">https://www.ohri.ca/programs/clinical_epidemiology/oxford.asp</ext-link>.</mixed-citation></ref><ref id="jep70029-bib-0030"><label>30</label><mixed-citation publication-type="journal" id="jep70029-cit-0030"><string-name name-style="western"><given-names>S.</given-names><surname>Nadkarni</surname></string-name>, <string-name name-style="western"><given-names>J.</given-names><surname>Ramesh</surname></string-name>, <string-name name-style="western"><given-names>A.</given-names><surname>Bk</surname></string-name>, and <string-name name-style="western"><given-names>K.</given-names><surname>Girish</surname></string-name>, &#8220;<article-title>A Prospective Observational Study on Pattern of Drug Use for Neuropathic Pain in a Tertiary Hospital</article-title>,&#8221; <source>Research Journal of Pharmaceutical, Biological and Chemical Sciences</source><volume>13</volume> (<year>2022</year>): <fpage>101</fpage>&#8211;<lpage>109</lpage>, <pub-id pub-id-type="doi">10.33887/rjpbcs/2022.13.4.16</pub-id>.</mixed-citation></ref><ref id="jep70029-bib-0031"><label>31</label><mixed-citation publication-type="journal" id="jep70029-cit-0031"><string-name name-style="western"><given-names>R. L.</given-names><surname>Robinson</surname></string-name>, <string-name name-style="western"><given-names>T. J.</given-names><surname>Schnitzer</surname></string-name>, <string-name name-style="western"><given-names>S.</given-names><surname>Barlow</surname></string-name>, et al., &#8220;<article-title>Satisfaction With Medications Prescribed for Osteoarthritis: A Cross&#8208;Sectional Survey of Patients and Their Physicians in the United States</article-title>,&#8221; <source>Pain and Therapy</source><volume>11</volume>, no. <issue>1</issue> (<year>2022</year>): <fpage>191</fpage>&#8211;<lpage>208</lpage>, <pub-id pub-id-type="doi">10.1007/s40122-021-00350-0</pub-id>.<pub-id pub-id-type="pmid">35028917</pub-id><pub-id pub-id-type="pmcid">PMC8861239</pub-id></mixed-citation></ref><ref id="jep70029-bib-0032"><label>32</label><mixed-citation publication-type="journal" id="jep70029-cit-0032"><string-name name-style="western"><given-names>N.</given-names><surname>Zinboonyahgoon</surname></string-name>, &#8220;<article-title>Cost&#8208;Utility and Cost&#8208;Effectiveness Analysis of Spinal Cord Stimulation for Chronic Refractory Pain in the Context of Developing Country</article-title>,&#8221; <source>Pain Physician Journal</source><volume>26</volume>, no. <issue>1</issue> (<year>2023</year>): <fpage>69</fpage>&#8211;<lpage>79</lpage>.<pub-id pub-id-type="pmid">36791296</pub-id></mixed-citation></ref><ref id="jep70029-bib-0033"><label>33</label><mixed-citation publication-type="journal" id="jep70029-cit-0033"><string-name name-style="western"><given-names>G. A.</given-names><surname>Moreira de Barros</surname></string-name>, <string-name name-style="western"><given-names>R.</given-names><surname>Baradelli</surname></string-name>, <string-name name-style="western"><given-names>D. G.</given-names><surname>Rodrigues</surname></string-name>, et al., &#8220;<article-title>Use of Methadone as an Alternative to Morphine for Chronic Pain Management: A Noninferiority Retrospective Observational Study</article-title>,&#8221; <source>Pain Reports</source><volume>6</volume>, no. <issue>4</issue> (<year>2021</year>): <elocation-id>e979</elocation-id>, <pub-id pub-id-type="doi">10.1097/pr9.0000000000000979</pub-id>.<pub-id pub-id-type="pmid">34938934</pub-id><pub-id pub-id-type="pmcid">PMC8687725</pub-id></mixed-citation></ref><ref id="jep70029-bib-0034"><label>34</label><mixed-citation publication-type="journal" id="jep70029-cit-0034"><string-name name-style="western"><given-names>A. P.</given-names><surname>Ganguly</surname></string-name>, <string-name name-style="western"><given-names>M. C.</given-names><surname>Lira</surname></string-name>, <string-name name-style="western"><given-names>S.</given-names><surname>Lodi</surname></string-name>, et al., &#8220;<article-title>Race and Satisfaction With Pain Management Among Patients With HIV Receiving Long&#8208;Term Opioid Therapy</article-title>,&#8221; <source>Drug and Alcohol Dependence</source><volume>222</volume> (<year>2021</year>): <elocation-id>108662</elocation-id>, <pub-id pub-id-type="doi">10.1016/j.drugalcdep.2021.108662</pub-id>.<pub-id pub-id-type="pmid">33775447</pub-id><pub-id pub-id-type="pmcid">PMC9215531</pub-id></mixed-citation></ref><ref id="jep70029-bib-0035"><label>35</label><mixed-citation publication-type="journal" id="jep70029-cit-0035"><string-name name-style="western"><given-names>J. A.</given-names><surname>Gudin</surname></string-name>, <string-name name-style="western"><given-names>D. T.</given-names><surname>Dietze</surname></string-name>, and <string-name name-style="western"><given-names>P. L.</given-names><surname>Hurwitz</surname></string-name>, &#8220;<article-title>Improvement of Pain and Function After Use of a Topical Pain Relieving Patch: Results of the Relief Study</article-title>,&#8221; <source>Journal of Pain Research</source><volume>13</volume> (<year>2020</year>): <fpage>1557</fpage>&#8211;<lpage>1568</lpage>, <pub-id pub-id-type="doi">10.2147/jpr.S258883</pub-id>.<pub-id pub-id-type="pmid">32617016</pub-id><pub-id pub-id-type="pmcid">PMC7326193</pub-id></mixed-citation></ref><ref id="jep70029-bib-0036"><label>36</label><mixed-citation publication-type="journal" id="jep70029-cit-0036"><string-name name-style="western"><given-names>J. L.</given-names><surname>Kabor&#233;</surname></string-name>, <string-name name-style="western"><given-names>H.</given-names><surname>Sa&#239;di</surname></string-name>, <string-name name-style="western"><given-names>L.</given-names><surname>Dassieu</surname></string-name>, <string-name name-style="western"><given-names>M.</given-names><surname>Choini&#232;re</surname></string-name>, and <string-name name-style="western"><given-names>M. G.</given-names><surname>Pag&#233;</surname></string-name>, &#8220;<article-title>Predictors of Long&#8208;Term Opioid Effectiveness in Patients With Chronic Non&#8208;Cancer Pain Attending Multidisciplinary Pain Treatment Clinics: A Quebec Pain Registry Study</article-title>,&#8221; <source>Pain Practice</source><volume>20</volume>, no. <issue>6</issue> (<year>2020</year>): <fpage>588</fpage>&#8211;<lpage>599</lpage>, <pub-id pub-id-type="doi">10.1111/papr.12883</pub-id>.<pub-id pub-id-type="pmid">32187793</pub-id></mixed-citation></ref><ref id="jep70029-bib-0037"><label>37</label><mixed-citation publication-type="journal" id="jep70029-cit-0037"><string-name name-style="western"><given-names>C.</given-names><surname>Ram&#237;rez&#8208;Maestre</surname></string-name>, <string-name name-style="western"><given-names>&#193;.</given-names><surname>Reyes&#8208;P&#233;rez</surname></string-name>, <string-name name-style="western"><given-names>R.</given-names><surname>Esteve</surname></string-name>, <string-name name-style="western"><given-names>A. E.</given-names><surname>L&#243;pez&#8208;Mart&#237;nez</surname></string-name>, <string-name name-style="western"><given-names>S.</given-names><surname>Bernardes</surname></string-name>, and <string-name name-style="western"><given-names>M. P.</given-names><surname>Jensen</surname></string-name>, &#8220;<article-title>Opioid Pain Medication Prescription for Chronic Pain in Primary Care Centers: The Roles of Pain Acceptance, Pain Intensity, Depressive Symptoms, Pain Catastrophizing, Sex, and Age</article-title>,&#8221; <source>International Journal of Environmental Research and Public Health</source><volume>17</volume>, no. <issue>17</issue> (<year>2020</year>): <elocation-id>6428</elocation-id>, <pub-id pub-id-type="doi">10.3390/ijerph17176428</pub-id>.<pub-id pub-id-type="pmid">32899359</pub-id><pub-id pub-id-type="pmcid">PMC7503487</pub-id></mixed-citation></ref><ref id="jep70029-bib-0038"><label>38</label><mixed-citation publication-type="journal" id="jep70029-cit-0038"><string-name name-style="western"><given-names>A.</given-names><surname>Sicras&#8208;Mainar</surname></string-name>, <string-name name-style="western"><given-names>C.</given-names><surname>Tornero&#8208;Tornero</surname></string-name>, <string-name name-style="western"><given-names>F.</given-names><surname>Vargas&#8208;Negr&#237;n</surname></string-name>, <string-name name-style="western"><given-names>I.</given-names><surname>Lizarraga</surname></string-name>, and <string-name name-style="western"><given-names>J.</given-names><surname>Rejas&#8208;Gutierrez</surname></string-name>, &#8220;<article-title>Health Outcomes and Costs in Patients With Osteoarthritis and Chronic Pain Treated With Opioids in Spain: The Opioids Real&#8208;World Study</article-title>,&#8221; <source>Therapeutic Advances in Musculoskeletal Disease</source><volume>12</volume> (<year>2020</year>): <elocation-id>1759720x20942000</elocation-id>, <pub-id pub-id-type="doi">10.1177/1759720x20942000</pub-id>.<pub-id pub-id-type="pmcid">PMC7502862</pub-id><pub-id pub-id-type="pmid">32994809</pub-id></mixed-citation></ref><ref id="jep70029-bib-0039"><label>39</label><mixed-citation publication-type="journal" id="jep70029-cit-0039"><string-name name-style="western"><given-names>S.</given-names><surname>Lee</surname></string-name>, <string-name name-style="western"><given-names>M. L.</given-names><surname>Smith</surname></string-name>, <string-name name-style="western"><given-names>D. V.</given-names><surname>Dahlke</surname></string-name>, <string-name name-style="western"><given-names>N.</given-names><surname>Pardo</surname></string-name>, and <string-name name-style="western"><given-names>M. G.</given-names><surname>Ory</surname></string-name>, &#8220;<article-title>A Cross&#8208;Sectional Examination of Patients' Perspectives About Their Pain, Pain Management, and Satisfaction With Pain Treatment</article-title>,&#8221; <source>Pain Medicine (Malden, Mass.)</source><volume>21</volume>, no. <issue>2</issue> (<year>2020</year>): <elocation-id>e164&#8208;e171</elocation-id>, <pub-id pub-id-type="doi">10.1093/pm/pnz244</pub-id>.<pub-id pub-id-type="pmid">31609389</pub-id></mixed-citation></ref><ref id="jep70029-bib-0040"><label>40</label><mixed-citation publication-type="journal" id="jep70029-cit-0040"><string-name name-style="western"><given-names>T.</given-names><surname>Taguchi</surname></string-name>, <string-name name-style="western"><given-names>K.</given-names><surname>Nozawa</surname></string-name>, <string-name name-style="western"><given-names>B.</given-names><surname>Parsons</surname></string-name>, et al., &#8220;<article-title>Effectiveness of Pregabalin for Treatment of Chronic Cervical Radiculopathy With Upper Limb Radiating Pain: An 8&#8208;week, Multicenter Prospective Observational Study in Japanese Primary Care Settings</article-title>,&#8221; <source>Journal of Pain Research</source><volume>12</volume> (<year>2019</year>): <fpage>1411</fpage>&#8211;<lpage>1424</lpage>, <pub-id pub-id-type="doi">10.2147/jpr.S191906</pub-id>.<pub-id pub-id-type="pmid">31118759</pub-id><pub-id pub-id-type="pmcid">PMC6506009</pub-id></mixed-citation></ref><ref id="jep70029-bib-0041"><label>41</label><mixed-citation publication-type="journal" id="jep70029-cit-0041"><string-name name-style="western"><given-names>P. M.</given-names><surname>Wayne</surname></string-name>, <string-name name-style="western"><given-names>J. E.</given-names><surname>Buring</surname></string-name>, <string-name name-style="western"><given-names>D. M.</given-names><surname>Eisenberg</surname></string-name>, et al., &#8220;<article-title>Cost&#8208;Effectiveness of a Team&#8208;Based Integrative Medicine Approach to the Treatment of Back Pain</article-title>,&#8221; supplement, <source>Journal of Alternative and Complementary Medicine</source><volume>25</volume>, no. <issue>S1</issue> (<year>2019</year>): <fpage>S138</fpage>&#8211;<lpage>S146</lpage>, <pub-id pub-id-type="doi">10.1089/acm.2018.0503</pub-id>.<pub-id pub-id-type="pmid">30870015</pub-id><pub-id pub-id-type="pmcid">PMC6444892</pub-id></mixed-citation></ref><ref id="jep70029-bib-0042"><label>42</label><mixed-citation publication-type="journal" id="jep70029-cit-0042"><string-name name-style="western"><given-names>K. S.</given-names><surname>McCann</surname></string-name>, <string-name name-style="western"><given-names>S.</given-names><surname>Barker</surname></string-name>, <string-name name-style="western"><given-names>R.</given-names><surname>Cousins</surname></string-name>, et al., &#8220;<article-title>Structured Management of Chronic Nonmalignant Pain With Opioids in a Rural Primary Care Office</article-title>,&#8221; <source>Journal of the American Board of Family Medicine</source><volume>31</volume>, no. <issue>1</issue> (<year>2018</year>): <fpage>57</fpage>&#8211;<lpage>63</lpage>, <pub-id pub-id-type="doi">10.3122/jabfm.2018.01.170163</pub-id>.<pub-id pub-id-type="pmid">29330240</pub-id></mixed-citation></ref><ref id="jep70029-bib-0043"><label>43</label><mixed-citation publication-type="journal" id="jep70029-cit-0043"><string-name name-style="western"><given-names>K.</given-names><surname>Elsesser</surname></string-name> and <string-name name-style="western"><given-names>T.</given-names><surname>Cegla</surname></string-name>, &#8220;<article-title>Long&#8208;Term Treatment in Chronic Noncancer Pain: Results of an Observational Study Comparing Opioid and Nonopioid Therapy</article-title>,&#8221; <source>Scandinavian Journal of Pain</source><volume>17</volume> (<year>2017</year>): <fpage>87</fpage>&#8211;<lpage>98</lpage>, <pub-id pub-id-type="doi">10.1016/j.sjpain.2017.07.005</pub-id>.<pub-id pub-id-type="pmid">28850379</pub-id></mixed-citation></ref><ref id="jep70029-bib-0044"><label>44</label><mixed-citation publication-type="journal" id="jep70029-cit-0044"><string-name name-style="western"><given-names>A.</given-names><surname>Ghodke</surname></string-name>, <string-name name-style="western"><given-names>S.</given-names><surname>Barquero</surname></string-name>, <string-name name-style="western"><given-names>P. R.</given-names><surname>Chelminski</surname></string-name>, and <string-name name-style="western"><given-names>T. J.</given-names><surname>Ives</surname></string-name>, &#8220;<article-title>Short&#8208;Acting Opioids Are Associated With Comparable Analgesia to Long&#8208;Acting Opioids in Patients With Chronic Osteoarthritis With a Reduced Opioid Equivalence Dosing</article-title>,&#8221; <source>Pain Medicine</source><volume>19</volume>, no. <issue>11</issue> (<year>2018</year>): <fpage>2191</fpage>&#8211;<lpage>2195</lpage>, <pub-id pub-id-type="doi">10.1093/pm/pnx245</pub-id>.<pub-id pub-id-type="pmid">29121327</pub-id></mixed-citation></ref><ref id="jep70029-bib-0045"><label>45</label><mixed-citation publication-type="journal" id="jep70029-cit-0045"><string-name name-style="western"><given-names>C. N.</given-names><surname>Vogler</surname></string-name>, <string-name name-style="western"><given-names>S.</given-names><surname>Sattovia</surname></string-name>, <string-name name-style="western"><given-names>L. Y.</given-names><surname>Salazar</surname></string-name>, <string-name name-style="western"><given-names>T. I.</given-names><surname>Leung</surname></string-name>, and <string-name name-style="western"><given-names>A.</given-names><surname>Botchway</surname></string-name>, &#8220;<article-title>Assessing Outcomes of Educational Videos in Group Visits for Patients With Chronic Pain at an Academic Primary Care Clinic</article-title>,&#8221; <source>Postgraduate Medicine</source><volume>129</volume>, no. <issue>5</issue> (<year>2017</year>): <fpage>524</fpage>&#8211;<lpage>530</lpage>, <pub-id pub-id-type="doi">10.1080/00325481.2017.1324228</pub-id>.<pub-id pub-id-type="pmid">28447542</pub-id></mixed-citation></ref><ref id="jep70029-bib-0046"><label>46</label><mixed-citation publication-type="journal" id="jep70029-cit-0046"><string-name name-style="western"><given-names>L. D.</given-names><surname>White</surname></string-name>, <string-name name-style="western"><given-names>P.</given-names><surname>Summers</surname></string-name>, and <string-name name-style="western"><given-names>A.</given-names><surname>Scott</surname></string-name>, &#8220;<article-title>Changes in Clinical Status After Completion of an Interdisciplinary Pain Management Programme Incorporating Pain Neurophysiology Education</article-title>,&#8221; <source>Physiotherapy Canada</source><volume>70</volume>, no. <issue>4</issue> (<year>2018</year>): <fpage>382</fpage>&#8211;<lpage>392</lpage>, <pub-id pub-id-type="doi">10.3138/ptc.2016-72.ep</pub-id>.<pub-id pub-id-type="pmid">30745724</pub-id><pub-id pub-id-type="pmcid">PMC6361396</pub-id></mixed-citation></ref><ref id="jep70029-bib-0047"><label>47</label><mixed-citation publication-type="journal" id="jep70029-cit-0047"><string-name name-style="western"><given-names>A.</given-names><surname>Igarashi</surname></string-name>, <string-name name-style="western"><given-names>M.</given-names><surname>Akazawa</surname></string-name>, <string-name name-style="western"><given-names>T.</given-names><surname>Murata</surname></string-name>, et al., &#8220;<article-title>Cost&#8208;Effectiveness Analysis of Pregabalin for Treatment of Chronic Low Back Pain in Patients With Accompanying Lower Limb Pain (Neuropathic Component) in Japan</article-title>,&#8221; <source>ClinicoEconomics and Outcomes Research: CEOR</source><volume>7</volume> (<year>2015</year>): <fpage>505</fpage>&#8211;<lpage>520</lpage>, <pub-id pub-id-type="doi">10.2147/ceor.S89833</pub-id>.<pub-id pub-id-type="pmid">26504403</pub-id><pub-id pub-id-type="pmcid">PMC4605243</pub-id></mixed-citation></ref><ref id="jep70029-bib-0048"><label>48</label><mixed-citation publication-type="journal" id="jep70029-cit-0048"><string-name name-style="western"><given-names>K. E.</given-names><surname>Dunn</surname></string-name>, <string-name name-style="western"><given-names>R. K.</given-names><surname>Brooner</surname></string-name>, and <string-name name-style="western"><given-names>M. R.</given-names><surname>Clark</surname></string-name>, &#8220;<article-title>Severity and Interference of Chronic Pain in Methadone&#8208;Maintained Outpatients</article-title>,&#8221; <source>Pain Medicine</source><volume>15</volume>, no. <issue>9</issue> (<year>2014</year>): <fpage>1540</fpage>&#8211;<lpage>1548</lpage>, <pub-id pub-id-type="doi">10.1111/pme.12430</pub-id>.<pub-id pub-id-type="pmid">24703517</pub-id></mixed-citation></ref><ref id="jep70029-bib-0049"><label>49</label><mixed-citation publication-type="journal" id="jep70029-cit-0049"><string-name name-style="western"><given-names>G.</given-names><surname>Jouini</surname></string-name>, <string-name name-style="western"><given-names>M.</given-names><surname>Choini&#232;re</surname></string-name>, <string-name name-style="western"><given-names>E.</given-names><surname>Martin</surname></string-name>, et al., &#8220;<article-title>Pharmacotherapeutic Management of Chronic Noncancer Pain in Primary Care: Lessons for Pharmacists</article-title>,&#8221; <source>Journal of Pain Research</source><volume>7</volume> (<year>2014</year>): <fpage>163</fpage>&#8211;<lpage>173</lpage>, <pub-id pub-id-type="doi">10.2147/jpr.S56884</pub-id>.<pub-id pub-id-type="pmid">24711711</pub-id><pub-id pub-id-type="pmcid">PMC3969347</pub-id></mixed-citation></ref><ref id="jep70029-bib-0050"><label>50</label><mixed-citation publication-type="journal" id="jep70029-cit-0050"><string-name name-style="western"><given-names>J.</given-names><surname>Ashworth</surname></string-name>, <string-name name-style="western"><given-names>D. J.</given-names><surname>Green</surname></string-name>, <string-name name-style="western"><given-names>K. M.</given-names><surname>Dunn</surname></string-name>, and <string-name name-style="western"><given-names>K. P.</given-names><surname>Jordan</surname></string-name>, &#8220;<article-title>Opioid Use Among Low Back Pain Patients in Primary Care: Is Opioid Prescription Associated With Disability at 6&#8208;month Follow&#8208;Up?</article-title>,&#8221; <source>Pain</source><volume>154</volume>, no. <issue>7</issue> (<year>2013</year>): <fpage>1038</fpage>&#8211;<lpage>1044</lpage>, <pub-id pub-id-type="doi">10.1016/j.pain.2013.03.011</pub-id>.<pub-id pub-id-type="pmid">23688575</pub-id><pub-id pub-id-type="pmcid">PMC4250559</pub-id></mixed-citation></ref><ref id="jep70029-bib-0051"><label>51</label><mixed-citation publication-type="journal" id="jep70029-cit-0051"><string-name name-style="western"><given-names>C.</given-names><surname>P&#233;rez</surname></string-name>, <string-name name-style="western"><given-names>A.</given-names><surname>Navarro</surname></string-name>, <string-name name-style="western"><given-names>M. T.</given-names><surname>Salda&#241;a</surname></string-name>, <string-name name-style="western"><given-names>X.</given-names><surname>Masram&#243;n</surname></string-name>, <string-name name-style="western"><given-names>M.</given-names><surname>P&#233;rez</surname></string-name>, and <string-name name-style="western"><given-names>J.</given-names><surname>Rejas</surname></string-name>, &#8220;<article-title>Clinical and Resource Utilization Patterns in Patients With Refractory Neuropathic Pain Prescribed Pregabalin for the First Time in Routine Medical Practice in Primary Care Settings in Spain</article-title>,&#8221; <source>Pain Medicine</source><volume>14</volume>, no. <issue>12</issue> (<year>2013</year>): <fpage>1954</fpage>&#8211;<lpage>1963</lpage>, <pub-id pub-id-type="doi">10.1111/pme.12276</pub-id>.<pub-id pub-id-type="pmid">24330229</pub-id></mixed-citation></ref><ref id="jep70029-bib-0052"><label>52</label><mixed-citation publication-type="journal" id="jep70029-cit-0052"><string-name name-style="western"><given-names>E.</given-names><surname>Blanco Tarrio</surname></string-name>, <string-name name-style="western"><given-names>R.</given-names><surname>G&#225;lvez Mateos</surname></string-name>, <string-name name-style="western"><given-names>E.</given-names><surname>Zamorano Bayarri</surname></string-name>, <string-name name-style="western"><given-names>V.</given-names><surname>L&#243;pez G&#243;mez</surname></string-name>, and <string-name name-style="western"><given-names>M.</given-names><surname>P&#233;rez P&#225;ramo</surname></string-name>, &#8220;<article-title>Effectiveness of Pregabalin as Monotherapy or Combination Therapy for Neuropathic Pain in Patients Unresponsive to Previous Treatments in a Spanish Primary Care Setting</article-title>,&#8221; <source>Clinical Drug Investigation</source><volume>33</volume>, no. <issue>9</issue> (<year>2013</year>): <fpage>633</fpage>&#8211;<lpage>645</lpage>, <pub-id pub-id-type="doi">10.1007/s40261-013-0116-7</pub-id>.<pub-id pub-id-type="pmid">23912474</pub-id><pub-id pub-id-type="pmcid">PMC3751224</pub-id></mixed-citation></ref><ref id="jep70029-bib-0053"><label>53</label><mixed-citation publication-type="journal" id="jep70029-cit-0053"><string-name name-style="western"><given-names>S.</given-names><surname>Dosenovic</surname></string-name>, <string-name name-style="western"><given-names>A.</given-names><surname>Jelicic Kadic</surname></string-name>, <string-name name-style="western"><given-names>M.</given-names><surname>Jeric</surname></string-name>, et al., &#8220;<article-title>Efficacy and Safety Outcome Domains and Outcome Measures in Systematic Reviews of Neuropathic Pain Conditions</article-title>,&#8221; <source>Clinical Journal of Pain</source><volume>34</volume>, no. <issue>7</issue> (<year>2018</year>): <fpage>674</fpage>&#8211;<lpage>684</lpage>, <pub-id pub-id-type="doi">10.1097/ajp.0000000000000574</pub-id>.<pub-id pub-id-type="pmid">29252868</pub-id></mixed-citation></ref><ref id="jep70029-bib-0054"><label>54</label><mixed-citation publication-type="journal" id="jep70029-cit-0054"><string-name name-style="western"><given-names>M.</given-names><surname>Haanp&#228;&#228;</surname></string-name>, <string-name name-style="western"><given-names>N.</given-names><surname>Attal</surname></string-name>, <string-name name-style="western"><given-names>M.</given-names><surname>Backonja</surname></string-name>, et al., &#8220;<article-title>Neupsig Guidelines on Neuropathic Pain Assessment</article-title>,&#8221; <source>Pain</source><volume>152</volume>, no. <issue>1</issue> (<year>2011</year>): <fpage>14</fpage>&#8211;<lpage>27</lpage>, <pub-id pub-id-type="doi">10.1016/j.pain.2010.07.031</pub-id>.<pub-id pub-id-type="pmid">20851519</pub-id></mixed-citation></ref><ref id="jep70029-bib-0055"><label>55</label><mixed-citation publication-type="journal" id="jep70029-cit-0055"><string-name name-style="western"><given-names>N.</given-names><surname>Bellamy</surname></string-name>, <string-name name-style="western"><given-names>J.</given-names><surname>Campbell</surname></string-name>, and <string-name name-style="western"><given-names>J.</given-names><surname>Syrotuik</surname></string-name>, &#8220;<article-title>Comparative Study of Self&#8208;Rating Pain Scales in Osteoarthritis Patients</article-title>,&#8221; <source>Current Medical Research and Opinion</source><volume>15</volume>, no. <issue>2</issue> (<year>1999</year>): <fpage>113</fpage>&#8211;<lpage>119</lpage>, <pub-id pub-id-type="doi">10.1185/03007999909113371</pub-id>.<pub-id pub-id-type="pmid">10494494</pub-id></mixed-citation></ref><ref id="jep70029-bib-0056"><label>56</label><mixed-citation publication-type="journal" id="jep70029-cit-0056"><string-name name-style="western"><given-names>N.</given-names><surname>Bellamy</surname></string-name>, <string-name name-style="western"><given-names>J.</given-names><surname>Campbell</surname></string-name>, and <string-name name-style="western"><given-names>J.</given-names><surname>Syrotuik</surname></string-name>, &#8220;<article-title>Comparative Study of Self&#8208;Rating Pain Scales in Rheumatoid Arthritis Patients</article-title>,&#8221; <source>Current Medical Research and Opinion</source><volume>15</volume>, no. <issue>2</issue> (<year>1999</year>): <fpage>121</fpage>&#8211;<lpage>127</lpage>, <pub-id pub-id-type="doi">10.1185/03007999909113372</pub-id>.<pub-id pub-id-type="pmid">10494495</pub-id></mixed-citation></ref><ref id="jep70029-bib-0057"><label>57</label><mixed-citation publication-type="journal" id="jep70029-cit-0057"><string-name name-style="western"><given-names>R. W.</given-names><surname>Poolman</surname></string-name>, <string-name name-style="western"><given-names>M. F.</given-names><surname>Swiontkowski</surname></string-name>, <string-name name-style="western"><given-names>J. C. T.</given-names><surname>Fairbank</surname></string-name>, <string-name name-style="western"><given-names>E. H.</given-names><surname>Schemitsch</surname></string-name>, <string-name name-style="western"><given-names>S.</given-names><surname>Sprague</surname></string-name>, and <string-name name-style="western"><given-names>H. C. W.</given-names><surname>de Vet</surname></string-name>, &#8220;<article-title>Outcome Instruments: Rationale for Their Use</article-title>,&#8221; supplement, <source>Journal of Bone and Joint Surgery</source><volume>91</volume>, no. <issue>S3</issue> (<year>2009</year>): <fpage>41</fpage>&#8211;<lpage>49</lpage>, <pub-id pub-id-type="doi">10.2106/jbjs.H.01551</pub-id>.<pub-id pub-id-type="pmcid">PMC2669748</pub-id><pub-id pub-id-type="pmid">19411499</pub-id></mixed-citation></ref><ref id="jep70029-bib-0058"><label>58</label><mixed-citation publication-type="journal" id="jep70029-cit-0058"><string-name name-style="western"><given-names>R. H.</given-names><surname>Dworkin</surname></string-name>, <string-name name-style="western"><given-names>D. C.</given-names><surname>Turk</surname></string-name>, <string-name name-style="western"><given-names>J. T.</given-names><surname>Farrar</surname></string-name>, et al., &#8220;<article-title>Core Outcome Measures for Chronic Pain Clinical Trials: Immpact Recommendations</article-title>,&#8221; <source>Pain</source><volume>113</volume>, no. <issue>1&#8211;2</issue> (<year>2005</year>): <fpage>9</fpage>&#8211;<lpage>19</lpage>, <pub-id pub-id-type="doi">10.1016/j.pain.2004.09.012</pub-id>.<pub-id pub-id-type="pmid">15621359</pub-id></mixed-citation></ref><ref id="jep70029-bib-0059"><label>59</label><mixed-citation publication-type="journal" id="jep70029-cit-0059"><string-name name-style="western"><given-names>C. B.</given-names><surname>Terwee</surname></string-name>, <string-name name-style="western"><given-names>M.</given-names><surname>Zuidgeest</surname></string-name>, <string-name name-style="western"><given-names>H. E.</given-names><surname>Vonkeman</surname></string-name>, <string-name name-style="western"><given-names>D.</given-names><surname>Cella</surname></string-name>, <string-name name-style="western"><given-names>L.</given-names><surname>Haverman</surname></string-name>, and <string-name name-style="western"><given-names>L. D.</given-names><surname>Roorda</surname></string-name>, &#8220;<article-title>Common Patient&#8208;Reported Outcomes Across ICHOM Standard Sets: The Potential Contribution of PROMIS&#174;</article-title>,&#8221; <source>BMC Medical Informatics and Decision Making</source><volume>21</volume>, no. <issue>1</issue> (<year>2021</year>): <fpage>259</fpage>, <pub-id pub-id-type="doi">10.1186/s12911-021-01624-5</pub-id>.<pub-id pub-id-type="pmid">34488730</pub-id><pub-id pub-id-type="pmcid">PMC8420145</pub-id></mixed-citation></ref></ref-list></back></article></pmc-articleset>